CA2671302A1 - Mirna regulated genes and pathways as targets for therapeutic intervention - Google Patents

Info

Publication number

CA2671302A1

CA2671302A1 CA002671302A CA2671302A CA2671302A1 CA 2671302 A1 CA2671302 A1 CA 2671302A1 CA 002671302 A CA002671302 A CA 002671302A CA 2671302 A CA2671302 A CA 2671302A CA 2671302 A1 CA2671302 A1 CA 2671302A1

Authority

CA

Canada

Prior art keywords

nucleic acid

cell

mir

mirna

carcinoma

Prior art date

2006-12-08

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 108091070501 miRNA Proteins 0.000 title claims abstract description 376
• 108090000623 proteins and genes Proteins 0.000 title claims abstract description 224
• 230000037361 pathway Effects 0.000 title claims abstract description 48
• 230000001105 regulatory effect Effects 0.000 title claims description 31
• 230000001225 therapeutic effect Effects 0.000 title description 32
• 239000002679 microRNA Substances 0.000 claims abstract description 377
• 238000000034 method Methods 0.000 claims abstract description 169
• 108091027943 miR-16 stem-loop Proteins 0.000 claims abstract description 125
• 239000000203 mixture Substances 0.000 claims abstract description 69
• 150000007523 nucleic acids Chemical class 0.000 claims description 236
• 102000039446 nucleic acids Human genes 0.000 claims description 212
• 108020004707 nucleic acids Proteins 0.000 claims description 212
• 210000004027 cell Anatomy 0.000 claims description 202
• 230000014509 gene expression Effects 0.000 claims description 165
• 206010028980 Neoplasm Diseases 0.000 claims description 125
• 239000003112 inhibitor Substances 0.000 claims description 102
• 238000002560 therapeutic procedure Methods 0.000 claims description 80
• 201000011510 cancer Diseases 0.000 claims description 72
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 63
• 201000010099 disease Diseases 0.000 claims description 62
• 230000001575 pathological effect Effects 0.000 claims description 44
• 210000001519 tissue Anatomy 0.000 claims description 43
• 230000004640 cellular pathway Effects 0.000 claims description 34
• 108020004414 DNA Proteins 0.000 claims description 26
• 208000000102 Squamous Cell Carcinoma of Head and Neck Diseases 0.000 claims description 25
• 201000001441 melanoma Diseases 0.000 claims description 25
• 206010033128 Ovarian cancer Diseases 0.000 claims description 23
• 206010060862 Prostate cancer Diseases 0.000 claims description 23
• 208000026310 Breast neoplasm Diseases 0.000 claims description 22
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 22
• 206010006187 Breast cancer Diseases 0.000 claims description 21
• 206010009944 Colon cancer Diseases 0.000 claims description 21
• 208000034578 Multiple myelomas Diseases 0.000 claims description 21
• 206010030155 Oesophageal carcinoma Diseases 0.000 claims description 21
• 206010035226 Plasma cell myeloma Diseases 0.000 claims description 21
• 206010017758 gastric cancer Diseases 0.000 claims description 21
• 208000001333 Colorectal Neoplasms Diseases 0.000 claims description 20
• 201000008275 breast carcinoma Diseases 0.000 claims description 20
• 201000010989 colorectal carcinoma Diseases 0.000 claims description 20
• 208000010749 gastric carcinoma Diseases 0.000 claims description 20
• 208000005017 glioblastoma Diseases 0.000 claims description 20
• 206010073071 hepatocellular carcinoma Diseases 0.000 claims description 20
• 231100000844 hepatocellular carcinoma Toxicity 0.000 claims description 20
• 208000008443 pancreatic carcinoma Diseases 0.000 claims description 20
• 201000001514 prostate carcinoma Diseases 0.000 claims description 20
• 201000000498 stomach carcinoma Diseases 0.000 claims description 20
• 206010014733 Endometrial cancer Diseases 0.000 claims description 19
• 206010014759 Endometrial neoplasm Diseases 0.000 claims description 19
• 208000021045 exocrine pancreatic carcinoma Diseases 0.000 claims description 19
• 201000000459 head and neck squamous cell carcinoma Diseases 0.000 claims description 19
• 208000002154 non-small cell lung carcinoma Diseases 0.000 claims description 19
• 206010003571 Astrocytoma Diseases 0.000 claims description 18
• 206010005003 Bladder cancer Diseases 0.000 claims description 18
• 208000024770 Thyroid neoplasm Diseases 0.000 claims description 18
• 201000001531 bladder carcinoma Diseases 0.000 claims description 18
• 201000003914 endometrial carcinoma Diseases 0.000 claims description 18
• 201000002510 thyroid cancer Diseases 0.000 claims description 18
• 208000010570 urinary bladder carcinoma Diseases 0.000 claims description 18
• 208000003950 B-cell lymphoma Diseases 0.000 claims description 17
• 208000033781 Thyroid carcinoma Diseases 0.000 claims description 17
• 208000013077 thyroid gland carcinoma Diseases 0.000 claims description 17
• 230000001965 increasing effect Effects 0.000 claims description 16
• 208000017604 Hodgkin disease Diseases 0.000 claims description 15
• 208000010747 Hodgkins lymphoma Diseases 0.000 claims description 15
• 208000021519 Hodgkin lymphoma Diseases 0.000 claims description 14
• 208000006265 Renal cell carcinoma Diseases 0.000 claims description 14
• 210000004369 blood Anatomy 0.000 claims description 14
• 239000008280 blood Substances 0.000 claims description 14
• 230000002829 reductive effect Effects 0.000 claims description 14
• 230000035945 sensitivity Effects 0.000 claims description 14
• 208000025205 Mantle-Cell Lymphoma Diseases 0.000 claims description 13
• 201000009410 rhabdomyosarcoma Diseases 0.000 claims description 12
• 206010066948 Myxofibrosarcoma Diseases 0.000 claims description 11
• 210000000481 breast Anatomy 0.000 claims description 11
• 210000004072 lung Anatomy 0.000 claims description 10
• 210000004556 brain Anatomy 0.000 claims description 9
• 208000006359 hepatoblastoma Diseases 0.000 claims description 9
• 208000025113 myeloid leukemia Diseases 0.000 claims description 9
• 230000003612 virological effect Effects 0.000 claims description 9
• 201000004404 Neurofibroma Diseases 0.000 claims description 8
• 208000028591 pheochromocytoma Diseases 0.000 claims description 8
• 230000002611 ovarian Effects 0.000 claims description 7
• 210000002307 prostate Anatomy 0.000 claims description 7
• 239000013598 vector Substances 0.000 claims description 7
• 206010023856 Laryngeal squamous cell carcinoma Diseases 0.000 claims description 6
• 208000000172 Medulloblastoma Diseases 0.000 claims description 6
• 206010027476 Metastases Diseases 0.000 claims description 6
• 210000003734 kidney Anatomy 0.000 claims description 6
• 210000004185 liver Anatomy 0.000 claims description 6
• 230000001537 neural effect Effects 0.000 claims description 6
• 239000013612 plasmid Substances 0.000 claims description 6
• 230000035755 proliferation Effects 0.000 claims description 6
• 210000002784 stomach Anatomy 0.000 claims description 6
• 108091070491 Homo sapiens miR-16-1 stem-loop Proteins 0.000 claims description 5
• 210000001072 colon Anatomy 0.000 claims description 5
• 230000002357 endometrial effect Effects 0.000 claims description 5
• 230000002518 glial effect Effects 0.000 claims description 5
• 210000001685 thyroid gland Anatomy 0.000 claims description 5
• 210000003932 urinary bladder Anatomy 0.000 claims description 5
• 108091068927 Homo sapiens miR-16-2 stem-loop Proteins 0.000 claims description 4
• 208000015181 infectious disease Diseases 0.000 claims description 4
• 230000009401 metastasis Effects 0.000 claims description 4
• 208000017897 Carcinoma of esophagus Diseases 0.000 claims description 3
• 108091028066 Mir-126 Proteins 0.000 claims description 3
• 210000000988 bone and bone Anatomy 0.000 claims description 3
• 230000002526 effect on cardiovascular system Effects 0.000 claims description 3
• 201000005619 esophageal carcinoma Diseases 0.000 claims description 3
• 230000002381 testicular Effects 0.000 claims description 3
• 230000004797 therapeutic response Effects 0.000 claims description 3
• 239000013603 viral vector Substances 0.000 claims description 3
• 208000035143 Bacterial infection Diseases 0.000 claims description 2
• 208000035473 Communicable disease Diseases 0.000 claims description 2
• 206010010356 Congenital anomaly Diseases 0.000 claims description 2
• 206010017533 Fungal infection Diseases 0.000 claims description 2
• 208000031888 Mycoses Diseases 0.000 claims description 2
• 208000030852 Parasitic disease Diseases 0.000 claims description 2
• 208000036142 Viral infection Diseases 0.000 claims description 2
• 230000001919 adrenal effect Effects 0.000 claims description 2
• 230000001580 bacterial effect Effects 0.000 claims description 2
• 208000022362 bacterial infectious disease Diseases 0.000 claims description 2
• 230000001079 digestive effect Effects 0.000 claims description 2
• 230000002124 endocrine Effects 0.000 claims description 2
• 230000001900 immune effect Effects 0.000 claims description 2
• 230000002458 infectious effect Effects 0.000 claims description 2
• 201000007270 liver cancer Diseases 0.000 claims description 2
• 208000014018 liver neoplasm Diseases 0.000 claims description 2
• 230000002503 metabolic effect Effects 0.000 claims description 2
• 210000000653 nervous system Anatomy 0.000 claims description 2
• 230000000241 respiratory effect Effects 0.000 claims description 2
• 230000035899 viability Effects 0.000 claims 2
• 230000002496 gastric effect Effects 0.000 claims 1
• 210000003205 muscle Anatomy 0.000 claims 1
• 230000003071 parasitic effect Effects 0.000 claims 1
• 230000002068 genetic effect Effects 0.000 abstract description 13
• 239000000523 sample Substances 0.000 description 100
• 125000003729 nucleotide group Chemical group 0.000 description 75
• 108010029485 Protein Isoforms Proteins 0.000 description 73
• 102000001708 Protein Isoforms Human genes 0.000 description 73
• 239000002773 nucleotide Substances 0.000 description 64
• 230000000295 complement effect Effects 0.000 description 56
• 238000011282 treatment Methods 0.000 description 51
• 239000002243 precursor Substances 0.000 description 42
• -1 miR-147 Proteins 0.000 description 41
• 229920002477 rna polymer Polymers 0.000 description 41
• 108020004999 messenger RNA Proteins 0.000 description 40
• 238000009396 hybridization Methods 0.000 description 34
• 102000004169 proteins and genes Human genes 0.000 description 33
• 235000018102 proteins Nutrition 0.000 description 31
• 230000000694 effects Effects 0.000 description 29
• 238000003491 array Methods 0.000 description 27
• 239000003795 chemical substances by application Substances 0.000 description 27
• 239000003550 marker Substances 0.000 description 27
• 230000000875 corresponding effect Effects 0.000 description 23
• 238000003556 assay Methods 0.000 description 22
• 102000053602 DNA Human genes 0.000 description 20
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 20
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 20
• 239000003153 chemical reaction reagent Substances 0.000 description 20
• 238000002372 labelling Methods 0.000 description 20
• 238000002347 injection Methods 0.000 description 19
• 239000007924 injection Substances 0.000 description 19
• 235000000346 sugar Nutrition 0.000 description 19
• 208000019065 cervical carcinoma Diseases 0.000 description 18
• 239000003814 drug Substances 0.000 description 18
• 230000006870 function Effects 0.000 description 17
• 201000005296 lung carcinoma Diseases 0.000 description 17
• 239000000243 solution Substances 0.000 description 17
• 230000003321 amplification Effects 0.000 description 16
• 230000027455 binding Effects 0.000 description 16
• 229940079593 drug Drugs 0.000 description 16
• 125000005647 linker group Chemical group 0.000 description 16
• 238000003199 nucleic acid amplification method Methods 0.000 description 16
• 238000001959 radiotherapy Methods 0.000 description 16
• 239000000126 substance Substances 0.000 description 16
• ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 14
• 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 14
• 238000009472 formulation Methods 0.000 description 14
• 238000012986 modification Methods 0.000 description 14
• 108700012411 TNFSF10 Proteins 0.000 description 13
• 102100024598 Tumor necrosis factor ligand superfamily member 10 Human genes 0.000 description 13
• 230000007423 decrease Effects 0.000 description 13
• 230000004048 modification Effects 0.000 description 13
• 239000012099 Alexa Fluor family Substances 0.000 description 12
• GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 12
• 208000024313 Testicular Neoplasms Diseases 0.000 description 12
• 230000004663 cell proliferation Effects 0.000 description 12
• 238000013461 design Methods 0.000 description 12
• 208000025189 neoplasm of testis Diseases 0.000 description 12
• 102000040430 polynucleotide Human genes 0.000 description 12
• 108091033319 polynucleotide Proteins 0.000 description 12
• 239000002157 polynucleotide Substances 0.000 description 12
• 201000003120 testicular cancer Diseases 0.000 description 12
• 206010073478 Anaplastic large-cell lymphoma Diseases 0.000 description 11
• 101100369992 Homo sapiens TNFSF10 gene Proteins 0.000 description 11
• 208000032004 Large-Cell Anaplastic Lymphoma Diseases 0.000 description 11
• 108020004711 Nucleic Acid Probes Proteins 0.000 description 11
• 230000033228 biological regulation Effects 0.000 description 11
• 238000002512 chemotherapy Methods 0.000 description 11
• 239000002853 nucleic acid probe Substances 0.000 description 11
• 102000004190 Enzymes Human genes 0.000 description 10
• 108090000790 Enzymes Proteins 0.000 description 10
• 230000006907 apoptotic process Effects 0.000 description 10
• 229910052799 carbon Inorganic materials 0.000 description 10
• 230000022131 cell cycle Effects 0.000 description 10
• 238000011161 development Methods 0.000 description 10
• 239000000975 dye Substances 0.000 description 10
• 229940088598 enzyme Drugs 0.000 description 10
• 229960002949 fluorouracil Drugs 0.000 description 10
• 238000009169 immunotherapy Methods 0.000 description 10
• 238000002493 microarray Methods 0.000 description 10
• 238000002360 preparation method Methods 0.000 description 10
• 238000004393 prognosis Methods 0.000 description 10
• 239000007787 solid Substances 0.000 description 10
• KDCGOANMDULRCW-UHFFFAOYSA-N Purine Natural products N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 9
• 230000001413 cellular effect Effects 0.000 description 9
• 230000018109 developmental process Effects 0.000 description 9
• 238000001415 gene therapy Methods 0.000 description 9
• 230000002401 inhibitory effect Effects 0.000 description 9
• 230000000670 limiting effect Effects 0.000 description 9
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
• 108700011259 MicroRNAs Proteins 0.000 description 8
• 102000002938 Thrombospondin Human genes 0.000 description 8
• 108060008245 Thrombospondin Proteins 0.000 description 8
• 238000004458 analytical method Methods 0.000 description 8
• 239000002246 antineoplastic agent Substances 0.000 description 8
• 230000008901 benefit Effects 0.000 description 8
• 239000000499 gel Substances 0.000 description 8
• 238000001356 surgical procedure Methods 0.000 description 8
• 230000014616 translation Effects 0.000 description 8
• 102000029791 ADAM Human genes 0.000 description 7
• 108091022885 ADAM Proteins 0.000 description 7
• 102000008102 Ankyrins Human genes 0.000 description 7
• 108010049777 Ankyrins Proteins 0.000 description 7
• 102000004127 Cytokines Human genes 0.000 description 7
• 108090000695 Cytokines Proteins 0.000 description 7
• 229930012538 Paclitaxel Natural products 0.000 description 7
• 108091007178 TNFRSF10A Proteins 0.000 description 7
• 102100040113 Tumor necrosis factor receptor superfamily member 10A Human genes 0.000 description 7
• HSCJRCZFDFQWRP-ABVWGUQPSA-N UDP-alpha-D-galactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-ABVWGUQPSA-N 0.000 description 7
• HSCJRCZFDFQWRP-UHFFFAOYSA-N Uridindiphosphoglukose Natural products OC1C(O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-UHFFFAOYSA-N 0.000 description 7
• 229940100198 alkylating agent Drugs 0.000 description 7
• 239000002168 alkylating agent Substances 0.000 description 7
• 150000001875 compounds Chemical class 0.000 description 7
• 230000003463 hyperproliferative effect Effects 0.000 description 7
• 230000001939 inductive effect Effects 0.000 description 7
• 230000005764 inhibitory process Effects 0.000 description 7
• 229960001592 paclitaxel Drugs 0.000 description 7
• 238000002271 resection Methods 0.000 description 7
• RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 7
• 238000013519 translation Methods 0.000 description 7
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
• OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 6
• ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 description 6
• 108091034117 Oligonucleotide Proteins 0.000 description 6
• 230000001594 aberrant effect Effects 0.000 description 6
• 239000003242 anti bacterial agent Substances 0.000 description 6
• 230000000259 anti-tumor effect Effects 0.000 description 6
• 239000012472 biological sample Substances 0.000 description 6
• 230000015572 biosynthetic process Effects 0.000 description 6
• 230000003247 decreasing effect Effects 0.000 description 6
• 239000011521 glass Substances 0.000 description 6
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 6
• 238000002955 isolation Methods 0.000 description 6
• 239000006166 lysate Substances 0.000 description 6
• 230000007246 mechanism Effects 0.000 description 6
• 239000012071 phase Substances 0.000 description 6
• 230000008569 process Effects 0.000 description 6
• 238000012545 processing Methods 0.000 description 6
• 230000005855 radiation Effects 0.000 description 6
• 230000009467 reduction Effects 0.000 description 6
• 230000004044 response Effects 0.000 description 6
• 210000003491 skin Anatomy 0.000 description 6
• 239000002904 solvent Substances 0.000 description 6
• 239000000758 substrate Substances 0.000 description 6
• 238000003786 synthesis reaction Methods 0.000 description 6
• 230000008685 targeting Effects 0.000 description 6
• 230000001988 toxicity Effects 0.000 description 6
• 231100000419 toxicity Toxicity 0.000 description 6
• 238000001890 transfection Methods 0.000 description 6
• 210000004881 tumor cell Anatomy 0.000 description 6
• 108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 description 5
• 102100036252 Cyclin-dependent kinase 4 Human genes 0.000 description 5
• CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 5
• 241001465754 Metazoa Species 0.000 description 5
• 229910019142 PO4 Inorganic materials 0.000 description 5
• 108091028664 Ribonucleotide Proteins 0.000 description 5
• 108020004459 Small interfering RNA Proteins 0.000 description 5
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 5
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 5
• 102100040112 Tumor necrosis factor receptor superfamily member 10B Human genes 0.000 description 5
• 125000000217 alkyl group Chemical group 0.000 description 5
• 230000004075 alteration Effects 0.000 description 5
• 238000013459 approach Methods 0.000 description 5
• 239000007864 aqueous solution Substances 0.000 description 5
• 239000000872 buffer Substances 0.000 description 5
• 230000010261 cell growth Effects 0.000 description 5
• 229960005395 cetuximab Drugs 0.000 description 5
• 238000006243 chemical reaction Methods 0.000 description 5
• 230000001472 cytotoxic effect Effects 0.000 description 5
• 238000001962 electrophoresis Methods 0.000 description 5
• 238000010195 expression analysis Methods 0.000 description 5
• 230000000394 mitotic effect Effects 0.000 description 5
• 239000002777 nucleoside Substances 0.000 description 5
• 238000011275 oncology therapy Methods 0.000 description 5
• 210000000056 organ Anatomy 0.000 description 5
• 230000002018 overexpression Effects 0.000 description 5
• 230000010412 perfusion Effects 0.000 description 5
• 239000010452 phosphate Substances 0.000 description 5
• 102000005962 receptors Human genes 0.000 description 5
• 108020003175 receptors Proteins 0.000 description 5
• 239000002336 ribonucleotide Substances 0.000 description 5
• 229960000575 trastuzumab Drugs 0.000 description 5
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 4
• VGIRNWJSIRVFRT-UHFFFAOYSA-N 2',7'-difluorofluorescein Chemical compound OC(=O)C1=CC=CC=C1C1=C2C=C(F)C(=O)C=C2OC2=CC(O)=C(F)C=C21 VGIRNWJSIRVFRT-UHFFFAOYSA-N 0.000 description 4
• 102100032047 Alsin Human genes 0.000 description 4
• 102100036131 Arginine-tRNA ligase, cytoplasmic Human genes 0.000 description 4
• 102100024458 Cyclin-dependent kinase inhibitor 2A Human genes 0.000 description 4
• UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 description 4
• AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 4
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• 101000610604 Homo sapiens Tumor necrosis factor receptor superfamily member 10B Proteins 0.000 description 4
• 239000005411 L01XE02 - Gefitinib Substances 0.000 description 4
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 4
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 4
• NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 4
• 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 4
• 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 4
• RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 4
• 229960000548 alemtuzumab Drugs 0.000 description 4
• 230000000340 anti-metabolite Effects 0.000 description 4
• 229940088710 antibiotic agent Drugs 0.000 description 4
• 239000000427 antigen Substances 0.000 description 4
• 102000036639 antigens Human genes 0.000 description 4
• 108091007433 antigens Proteins 0.000 description 4
• 229940100197 antimetabolite Drugs 0.000 description 4
• 239000002256 antimetabolite Substances 0.000 description 4
• 239000011324 bead Substances 0.000 description 4
• WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 4
• 108010005774 beta-Galactosidase Proteins 0.000 description 4
• 229960002685 biotin Drugs 0.000 description 4
• 235000020958 biotin Nutrition 0.000 description 4
• 239000011616 biotin Substances 0.000 description 4
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
• 230000030833 cell death Effects 0.000 description 4
• 229960004316 cisplatin Drugs 0.000 description 4
• DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 4
• 229960004397 cyclophosphamide Drugs 0.000 description 4
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
• 229940127089 cytotoxic agent Drugs 0.000 description 4
• 239000005547 deoxyribonucleotide Substances 0.000 description 4
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 4
• 239000006185 dispersion Substances 0.000 description 4
• VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 4
• 238000002866 fluorescence resonance energy transfer Methods 0.000 description 4
• 229960002584 gefitinib Drugs 0.000 description 4
• XGALLCVXEZPNRQ-UHFFFAOYSA-N gefitinib Chemical compound C=12C=C(OCCCN3CCOCC3)C(OC)=CC2=NC=NC=1NC1=CC=C(F)C(Cl)=C1 XGALLCVXEZPNRQ-UHFFFAOYSA-N 0.000 description 4
• ZRALSGWEFCBTJO-UHFFFAOYSA-O guanidinium Chemical compound NC(N)=[NH2+] ZRALSGWEFCBTJO-UHFFFAOYSA-O 0.000 description 4
• 108091023663 let-7 stem-loop Proteins 0.000 description 4
• 108091063478 let-7-1 stem-loop Proteins 0.000 description 4
• 108091049777 let-7-2 stem-loop Proteins 0.000 description 4
• 208000032839 leukemia Diseases 0.000 description 4
• 239000007788 liquid Substances 0.000 description 4
• 230000002934 lysing effect Effects 0.000 description 4
• 238000004519 manufacturing process Methods 0.000 description 4
• 239000011159 matrix material Substances 0.000 description 4
• HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical compound ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 description 4
• 239000013642 negative control Substances 0.000 description 4
• 238000003499 nucleic acid array Methods 0.000 description 4
• 238000007899 nucleic acid hybridization Methods 0.000 description 4
• 150000003833 nucleoside derivatives Chemical class 0.000 description 4
• 239000000843 powder Substances 0.000 description 4
• 230000002285 radioactive effect Effects 0.000 description 4
• 230000008439 repair process Effects 0.000 description 4
• PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 4
• 208000024891 symptom Diseases 0.000 description 4
• 229960005267 tositumomab Drugs 0.000 description 4
• 230000032258 transport Effects 0.000 description 4
• 239000003981 vehicle Substances 0.000 description 4
• 102100036659 26S proteasome non-ATPase regulatory subunit 9 Human genes 0.000 description 3
• 230000005730 ADP ribosylation Effects 0.000 description 3
• 102100039650 ADP-ribosylation factor-like protein 2 Human genes 0.000 description 3
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
• 102000004373 Actin-related protein 2 Human genes 0.000 description 3
• 108090000963 Actin-related protein 2 Proteins 0.000 description 3
• 208000031261 Acute myeloid leukaemia Diseases 0.000 description 3
• 108010077847 Adaptor Protein Complex 1 Proteins 0.000 description 3
• 102000010651 Adaptor Protein Complex 1 Human genes 0.000 description 3
• 108010077852 Adaptor Protein Complex 2 Proteins 0.000 description 3
• 102000010650 Adaptor Protein Complex 2 Human genes 0.000 description 3
• 108010077835 Adaptor Protein Complex 3 Proteins 0.000 description 3
• 102000010646 Adaptor Protein Complex 3 Human genes 0.000 description 3
• 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 3
• 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 3
• 102000014303 Amyloid beta-Protein Precursor Human genes 0.000 description 3
• 108010079054 Amyloid beta-Protein Precursor Proteins 0.000 description 3
• 102100033393 Anillin Human genes 0.000 description 3
• 102100034611 Ankyrin repeat domain-containing protein 12 Human genes 0.000 description 3
• 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 3
• 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 3
• 108091012583 BCL2 Proteins 0.000 description 3
• 102000008836 BTB/POZ domains Human genes 0.000 description 3
• 108050000749 BTB/POZ domains Proteins 0.000 description 3
• 108010006654 Bleomycin Proteins 0.000 description 3
• COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 3
• 108091007914 CDKs Proteins 0.000 description 3
• KLWPJMFMVPTNCC-UHFFFAOYSA-N Camptothecin Natural products CCC1(O)C(=O)OCC2=C1C=C3C4Nc5ccccc5C=C4CN3C2=O KLWPJMFMVPTNCC-UHFFFAOYSA-N 0.000 description 3
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
• 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 3
• 108010009392 Cyclin-Dependent Kinase Inhibitor p16 Proteins 0.000 description 3
• 102000009508 Cyclin-Dependent Kinase Inhibitor p16 Human genes 0.000 description 3
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
• 241000196324 Embryophyta Species 0.000 description 3
• 241000206602 Eukaryota Species 0.000 description 3
• 101000886101 Homo sapiens ADP-ribosylation factor-like protein 2 Proteins 0.000 description 3
• 101000776160 Homo sapiens Alsin Proteins 0.000 description 3
• 101000732632 Homo sapiens Anillin Proteins 0.000 description 3
• 101000924485 Homo sapiens Ankyrin repeat domain-containing protein 12 Proteins 0.000 description 3
• 101000959437 Homo sapiens Beta-2 adrenergic receptor Proteins 0.000 description 3
• 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 3
• 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 description 3
• 206010020843 Hyperthermia Diseases 0.000 description 3
• 108010002350 Interleukin-2 Proteins 0.000 description 3
• 102100020873 Interleukin-2 Human genes 0.000 description 3
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 3
• 108091027977 Mir-200 Proteins 0.000 description 3
• 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 3
• 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 3
• 239000004677 Nylon Substances 0.000 description 3
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 3
• 108010040945 Plasma Membrane Calcium-Transporting ATPases Proteins 0.000 description 3
• 102000002141 Plasma Membrane Calcium-Transporting ATPases Human genes 0.000 description 3
• 101710124239 Poly(A) polymerase Proteins 0.000 description 3
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 3
• 108010039518 Proton-Translocating ATPases Proteins 0.000 description 3
• 102000015176 Proton-Translocating ATPases Human genes 0.000 description 3
• 102100025642 Rho GDP-dissociation inhibitor 1 Human genes 0.000 description 3
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
• 108010037026 Vacuolar Proton-Translocating ATPases Proteins 0.000 description 3
• 102000011731 Vacuolar Proton-Translocating ATPases Human genes 0.000 description 3
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
• 230000009471 action Effects 0.000 description 3
• 230000003213 activating effect Effects 0.000 description 3
• 239000004480 active ingredient Substances 0.000 description 3
• 239000012491 analyte Substances 0.000 description 3
• 230000004900 autophagic degradation Effects 0.000 description 3
• 210000003719 b-lymphocyte Anatomy 0.000 description 3
• 229960000397 bevacizumab Drugs 0.000 description 3
• 238000001574 biopsy Methods 0.000 description 3
• 229960001561 bleomycin Drugs 0.000 description 3
• OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 3
• 229960002092 busulfan Drugs 0.000 description 3
• VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical compound C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 description 3
• 229940127093 camptothecin Drugs 0.000 description 3
• 239000012830 cancer therapeutic Substances 0.000 description 3
• 125000004432 carbon atom Chemical group C* 0.000 description 3
• 230000021164 cell adhesion Effects 0.000 description 3
• 229960004630 chlorambucil Drugs 0.000 description 3
• JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 description 3
• 238000004587 chromatography analysis Methods 0.000 description 3
• 238000011498 curative surgery Methods 0.000 description 3
• 229960000684 cytarabine Drugs 0.000 description 3
• 230000006378 damage Effects 0.000 description 3
• 239000003599 detergent Substances 0.000 description 3
• 230000004069 differentiation Effects 0.000 description 3
• VSJKWCGYPAHWDS-UHFFFAOYSA-N dl-camptothecin Natural products C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-UHFFFAOYSA-N 0.000 description 3
• 229960003668 docetaxel Drugs 0.000 description 3
• 239000012636 effector Substances 0.000 description 3
• 238000005516 engineering process Methods 0.000 description 3
• 230000002255 enzymatic effect Effects 0.000 description 3
• 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 3
• 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 3
• 102000015694 estrogen receptors Human genes 0.000 description 3
• 108010038795 estrogen receptors Proteins 0.000 description 3
• 238000011156 evaluation Methods 0.000 description 3
• 239000012530 fluid Substances 0.000 description 3
• 239000012634 fragment Substances 0.000 description 3
• SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 description 3
• 229960005277 gemcitabine Drugs 0.000 description 3
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
• 230000036031 hyperthermia Effects 0.000 description 3
• 229960001101 ifosfamide Drugs 0.000 description 3
• HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 description 3
• 238000000338 in vitro Methods 0.000 description 3
• 230000006698 induction Effects 0.000 description 3
• 239000007972 injectable composition Substances 0.000 description 3
• 238000007918 intramuscular administration Methods 0.000 description 3
• 230000002601 intratumoral effect Effects 0.000 description 3
• 230000003902 lesion Effects 0.000 description 3
• 239000003446 ligand Substances 0.000 description 3
• 201000005202 lung cancer Diseases 0.000 description 3
• 208000020816 lung neoplasm Diseases 0.000 description 3
• 239000000463 material Substances 0.000 description 3
• 229960004961 mechlorethamine Drugs 0.000 description 3
• 229960001924 melphalan Drugs 0.000 description 3
• SGDBTWWWUNNDEQ-LBPRGKRZSA-N melphalan Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N(CCCl)CCCl)C=C1 SGDBTWWWUNNDEQ-LBPRGKRZSA-N 0.000 description 3
• 229910052751 metal Inorganic materials 0.000 description 3
• 239000002184 metal Substances 0.000 description 3
• 229960000485 methotrexate Drugs 0.000 description 3
• 108091057645 miR-15 stem-loop Proteins 0.000 description 3
• 108091028751 miR-188 stem-loop Proteins 0.000 description 3
• 108091062762 miR-21 stem-loop Proteins 0.000 description 3
• 108091041631 miR-21-1 stem-loop Proteins 0.000 description 3
• 108091044442 miR-21-2 stem-loop Proteins 0.000 description 3
• 244000005700 microbiome Species 0.000 description 3
• YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 3
• 210000005170 neoplastic cell Anatomy 0.000 description 3
• 238000001668 nucleic acid synthesis Methods 0.000 description 3
• 229920001778 nylon Polymers 0.000 description 3
• 239000002751 oligonucleotide probe Substances 0.000 description 3
• 238000002515 oligonucleotide synthesis Methods 0.000 description 3
• 239000008194 pharmaceutical composition Substances 0.000 description 3
• 229920001223 polyethylene glycol Polymers 0.000 description 3
• 230000002265 prevention Effects 0.000 description 3
• 238000003757 reverse transcription PCR Methods 0.000 description 3
• 125000002652 ribonucleotide group Chemical group 0.000 description 3
• 229960004641 rituximab Drugs 0.000 description 3
• 150000003839 salts Chemical class 0.000 description 3
• 238000011301 standard therapy Methods 0.000 description 3
• 230000004936 stimulating effect Effects 0.000 description 3
• 238000007920 subcutaneous administration Methods 0.000 description 3
• 230000004083 survival effect Effects 0.000 description 3
• 229940063683 taxotere Drugs 0.000 description 3
• 229960003048 vinblastine Drugs 0.000 description 3
• 229960004528 vincristine Drugs 0.000 description 3
• OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 3
• OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 3
• GBABOYUKABKIAF-IELIFDKJSA-N vinorelbine Chemical compound C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC([C@]23[C@H]([C@@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC GBABOYUKABKIAF-IELIFDKJSA-N 0.000 description 3
• 229960002066 vinorelbine Drugs 0.000 description 3
• 239000011701 zinc Substances 0.000 description 3
• 229910052725 zinc Inorganic materials 0.000 description 3
• MWWSFMDVAYGXBV-MYPASOLCSA-N (7r,9s)-7-[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione;hydrochloride Chemical compound Cl.O([C@@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 MWWSFMDVAYGXBV-MYPASOLCSA-N 0.000 description 2
• GXVUZYLYWKWJIM-UHFFFAOYSA-N 2-(2-aminoethoxy)ethanamine Chemical compound NCCOCCN GXVUZYLYWKWJIM-UHFFFAOYSA-N 0.000 description 2
• MJKVTPMWOKAVMS-UHFFFAOYSA-N 3-hydroxy-1-benzopyran-2-one Chemical compound C1=CC=C2OC(=O)C(O)=CC2=C1 MJKVTPMWOKAVMS-UHFFFAOYSA-N 0.000 description 2
• 102100026188 3-hydroxybutyrate dehydrogenase type 2 Human genes 0.000 description 2
• 102100035923 4-aminobutyrate aminotransferase, mitochondrial Human genes 0.000 description 2
• 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 2
• STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 2
• LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
• 102100028220 ABI gene family member 3 Human genes 0.000 description 2
• 102100029770 ADAMTS-like protein 2 Human genes 0.000 description 2
• 102100029377 ADAMTS-like protein 3 Human genes 0.000 description 2
• 102100023818 ADP-ribosylation factor 3 Human genes 0.000 description 2
• 102100022908 ADP-ribosylation factor-like protein 1 Human genes 0.000 description 2
• 102100039646 ADP-ribosylation factor-like protein 3 Human genes 0.000 description 2
• 102100022870 ADP-ribosylation factor-like protein 5B Human genes 0.000 description 2
• 102000017919 ADRB2 Human genes 0.000 description 2
• 102100024378 AF4/FMR2 family member 2 Human genes 0.000 description 2
• 102100026607 ALS2 C-terminal-like protein Human genes 0.000 description 2
• 102100032897 AMP deaminase 2 Human genes 0.000 description 2
• 102100037651 AP-2 complex subunit sigma Human genes 0.000 description 2
• 101150034092 ATG4 gene Proteins 0.000 description 2
• 102100033094 ATP-binding cassette sub-family G member 4 Human genes 0.000 description 2
• 108091006112 ATPases Proteins 0.000 description 2
• 102100022523 Acetoacetyl-CoA synthetase Human genes 0.000 description 2
• 102100039164 Acetyl-CoA carboxylase 1 Human genes 0.000 description 2
• 102100021641 Acetyl-CoA carboxylase 2 Human genes 0.000 description 2
• 102100035709 Acetyl-coenzyme A synthetase, cytoplasmic Human genes 0.000 description 2
• 102100022099 Acid-sensing ion channel 4 Human genes 0.000 description 2
• 102100024322 Actin-related protein 8 Human genes 0.000 description 2
• 102000007469 Actins Human genes 0.000 description 2
• 108010085238 Actins Proteins 0.000 description 2
• 102100021886 Activin receptor type-2A Human genes 0.000 description 2
• 102100025848 Acyl-coenzyme A thioesterase 8 Human genes 0.000 description 2
• 102100034534 Adenomatous polyposis coli protein 2 Human genes 0.000 description 2
• 102000057290 Adenosine Triphosphatases Human genes 0.000 description 2
• 102100036664 Adenosine deaminase Human genes 0.000 description 2
• 102100032152 Adenylate cyclase type 7 Human genes 0.000 description 2
• 102100032156 Adenylate cyclase type 9 Human genes 0.000 description 2
• 102100020786 Adenylosuccinate synthetase isozyme 2 Human genes 0.000 description 2
• 102100032605 Adhesion G protein-coupled receptor B1 Human genes 0.000 description 2
• 102100036774 Afamin Human genes 0.000 description 2
• 102100040026 Agrin Human genes 0.000 description 2
• IKYJCHYORFJFRR-UHFFFAOYSA-N Alexa Fluor 350 Chemical compound O=C1OC=2C=C(N)C(S(O)(=O)=O)=CC=2C(C)=C1CC(=O)ON1C(=O)CCC1=O IKYJCHYORFJFRR-UHFFFAOYSA-N 0.000 description 2
• JLDSMZIBHYTPPR-UHFFFAOYSA-N Alexa Fluor 405 Chemical compound CC[NH+](CC)CC.CC[NH+](CC)CC.CC[NH+](CC)CC.C12=C3C=4C=CC2=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C1=CC=C3C(S(=O)(=O)[O-])=CC=4OCC(=O)N(CC1)CCC1C(=O)ON1C(=O)CCC1=O JLDSMZIBHYTPPR-UHFFFAOYSA-N 0.000 description 2
• WEJVZSAYICGDCK-UHFFFAOYSA-N Alexa Fluor 430 Chemical compound CC[NH+](CC)CC.CC1(C)C=C(CS([O-])(=O)=O)C2=CC=3C(C(F)(F)F)=CC(=O)OC=3C=C2N1CCCCCC(=O)ON1C(=O)CCC1=O WEJVZSAYICGDCK-UHFFFAOYSA-N 0.000 description 2
• WHVNXSBKJGAXKU-UHFFFAOYSA-N Alexa Fluor 532 Chemical compound [H+].[H+].CC1(C)C(C)NC(C(=C2OC3=C(C=4C(C(C(C)N=4)(C)C)=CC3=3)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=C2C=3C(C=C1)=CC=C1C(=O)ON1C(=O)CCC1=O WHVNXSBKJGAXKU-UHFFFAOYSA-N 0.000 description 2
• ZAINTDRBUHCDPZ-UHFFFAOYSA-M Alexa Fluor 546 Chemical compound [H+].[Na+].CC1CC(C)(C)NC(C(=C2OC3=C(C4=NC(C)(C)CC(C)C4=CC3=3)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=C2C=3C(C(=C(Cl)C=1Cl)C(O)=O)=C(Cl)C=1SCC(=O)NCCCCCC(=O)ON1C(=O)CCC1=O ZAINTDRBUHCDPZ-UHFFFAOYSA-M 0.000 description 2
• IGAZHQIYONOHQN-UHFFFAOYSA-N Alexa Fluor 555 Chemical compound C=12C=CC(=N)C(S(O)(=O)=O)=C2OC2=C(S(O)(=O)=O)C(N)=CC=C2C=1C1=CC=C(C(O)=O)C=C1C(O)=O IGAZHQIYONOHQN-UHFFFAOYSA-N 0.000 description 2
• 102100033806 Alpha-protein kinase 3 Human genes 0.000 description 2
• 208000024827 Alzheimer disease Diseases 0.000 description 2
• 102100039338 Aminomethyltransferase, mitochondrial Human genes 0.000 description 2
• 102100040038 Amyloid beta precursor like protein 2 Human genes 0.000 description 2
• 102100033695 Anaphase-promoting complex subunit 13 Human genes 0.000 description 2
• 102100040359 Angiomotin-like protein 2 Human genes 0.000 description 2
• 102100030988 Angiotensin-converting enzyme Human genes 0.000 description 2
• 102100033895 Ankyrin repeat and SOCS box protein 15 Human genes 0.000 description 2
• 102100021618 Ankyrin repeat and SOCS box protein 6 Human genes 0.000 description 2
• 102100023004 Ankyrin repeat domain-containing protein 13D Human genes 0.000 description 2
• 102100034277 Ankyrin repeat domain-containing protein 29 Human genes 0.000 description 2
• 102100033368 Ankyrin repeat domain-containing protein 39 Human genes 0.000 description 2
• 102100039179 Ankyrin repeat domain-containing protein 46 Human genes 0.000 description 2
• 102100031366 Ankyrin-1 Human genes 0.000 description 2
• 102100036818 Ankyrin-2 Human genes 0.000 description 2
• 102100034613 Annexin A2 Human genes 0.000 description 2
• 102100037320 Apolipoprotein A-IV Human genes 0.000 description 2
• 108010071619 Apolipoproteins Proteins 0.000 description 2
• 102000007592 Apolipoproteins Human genes 0.000 description 2
• 102100024044 Aprataxin Human genes 0.000 description 2
• 102000004888 Aquaporin 1 Human genes 0.000 description 2
• 108090001004 Aquaporin 1 Proteins 0.000 description 2
• 108010036221 Aquaporin 2 Proteins 0.000 description 2
• 108010036280 Aquaporin 4 Proteins 0.000 description 2
• 102100034414 Aquaporin-2 Human genes 0.000 description 2
• 102100037276 Aquaporin-4 Human genes 0.000 description 2
• 102100029463 Aquaporin-8 Human genes 0.000 description 2
• 108010014885 Arginine-tRNA ligase Proteins 0.000 description 2
• 102000016904 Armadillo Domain Proteins Human genes 0.000 description 2
• 108010014223 Armadillo Domain Proteins Proteins 0.000 description 2
• 102100034224 Armadillo repeat-containing X-linked protein 2 Human genes 0.000 description 2
• 102100023186 Armadillo repeat-containing protein 6 Human genes 0.000 description 2
• 102100021038 Arrestin domain-containing protein 4 Human genes 0.000 description 2
• 102100030907 Aryl hydrocarbon receptor nuclear translocator Human genes 0.000 description 2
• 102100033887 Arylsulfatase D Human genes 0.000 description 2
• 102100022108 Aspartyl/asparaginyl beta-hydroxylase Human genes 0.000 description 2
• 102100027708 Astrotactin-1 Human genes 0.000 description 2
• 102100023002 Ataxin-7-like protein 2 Human genes 0.000 description 2
• 102000007370 Ataxin2 Human genes 0.000 description 2
• 108010032951 Ataxin2 Proteins 0.000 description 2
• 102100020823 Autophagy-related protein 9A Human genes 0.000 description 2
• 102100020826 Autophagy-related protein 9B Human genes 0.000 description 2
• 102100035683 Axin-2 Human genes 0.000 description 2
• 102100021630 B-cell CLL/lymphoma 7 protein family member A Human genes 0.000 description 2
• 102100032426 B-cell CLL/lymphoma 7 protein family member B Human genes 0.000 description 2
• 102100032481 B-cell CLL/lymphoma 9 protein Human genes 0.000 description 2
• 102100032424 B-cell CLL/lymphoma 9-like protein Human genes 0.000 description 2
• 102100035730 B-cell receptor-associated protein 31 Human genes 0.000 description 2
• 102100027954 BAG family molecular chaperone regulator 3 Human genes 0.000 description 2
• 102100027955 BAG family molecular chaperone regulator 4 Human genes 0.000 description 2
• 102100028046 BAG family molecular chaperone regulator 5 Human genes 0.000 description 2
• MLDQJTXFUGDVEO-UHFFFAOYSA-N BAY-43-9006 Chemical compound C1=NC(C(=O)NC)=CC(OC=2C=CC(NC(=O)NC=3C=C(C(Cl)=CC=3)C(F)(F)F)=CC=2)=C1 MLDQJTXFUGDVEO-UHFFFAOYSA-N 0.000 description 2
• 102100021247 BCL-6 corepressor Human genes 0.000 description 2
• 102000017915 BDKRB2 Human genes 0.000 description 2
• 108091032955 Bacterial small RNA Proteins 0.000 description 2
• 206010004146 Basal cell carcinoma Diseases 0.000 description 2
• 102100021573 Bcl-2-binding component 3, isoforms 3/4 Human genes 0.000 description 2
• 102100024348 Beta-adducin Human genes 0.000 description 2
• 102100021277 Beta-secretase 2 Human genes 0.000 description 2
• 208000003174 Brain Neoplasms Diseases 0.000 description 2
• 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 2
• 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 2
• 102100026008 Breakpoint cluster region protein Human genes 0.000 description 2
• 102100028243 Breast carcinoma-amplified sequence 1 Human genes 0.000 description 2
• 102100026435 Breast carcinoma-amplified sequence 4 Human genes 0.000 description 2
• 102000001805 Bromodomains Human genes 0.000 description 2
• 108050009021 Bromodomains Proteins 0.000 description 2
• 102100040399 C->U-editing enzyme APOBEC-2 Human genes 0.000 description 2
• 102100021943 C-C motif chemokine 2 Human genes 0.000 description 2
• 101710155857 C-C motif chemokine 2 Proteins 0.000 description 2
• GAGWJHPBXLXJQN-UORFTKCHSA-N Capecitabine Chemical compound C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](C)O1 GAGWJHPBXLXJQN-UORFTKCHSA-N 0.000 description 2
• GAGWJHPBXLXJQN-UHFFFAOYSA-N Capecitabine Natural products C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1C1C(O)C(O)C(C)O1 GAGWJHPBXLXJQN-UHFFFAOYSA-N 0.000 description 2
• 102100024423 Carbonic anhydrase 9 Human genes 0.000 description 2
• 102000014914 Carrier Proteins Human genes 0.000 description 2
• 102000000844 Cell Surface Receptors Human genes 0.000 description 2
• 108010001857 Cell Surface Receptors Proteins 0.000 description 2
• 102100027835 Cell death regulator Aven Human genes 0.000 description 2
• 102000019034 Chemokines Human genes 0.000 description 2
• 108010012236 Chemokines Proteins 0.000 description 2
• 102100028289 Coatomer subunit delta Human genes 0.000 description 2
• 108091026890 Coding region Proteins 0.000 description 2
• 102100021645 Complex I assembly factor ACAD9, mitochondrial Human genes 0.000 description 2
• 102100027587 Copper-transporting ATPase 1 Human genes 0.000 description 2
• 102100027591 Copper-transporting ATPase 2 Human genes 0.000 description 2
• 102100023583 Cyclic AMP-dependent transcription factor ATF-6 alpha Human genes 0.000 description 2
• IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 2
• 102100032218 Cytokine-inducible SH2-containing protein Human genes 0.000 description 2
• 101710132484 Cytokine-inducible SH2-containing protein Proteins 0.000 description 2
• 102100023044 Cytosolic acyl coenzyme A thioester hydrolase Human genes 0.000 description 2
• 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 2
• 102100029764 DNA-directed DNA/RNA polymerase mu Human genes 0.000 description 2
• 108010092160 Dactinomycin Proteins 0.000 description 2
• ZBNZXTGUTAYRHI-UHFFFAOYSA-N Dasatinib Chemical compound C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1Cl ZBNZXTGUTAYRHI-UHFFFAOYSA-N 0.000 description 2
• 241000289632 Dasypodidae Species 0.000 description 2
• 102000010170 Death domains Human genes 0.000 description 2
• 108050001718 Death domains Proteins 0.000 description 2
• 108010053770 Deoxyribonucleases Proteins 0.000 description 2
• 102000016911 Deoxyribonucleases Human genes 0.000 description 2
• 102100031107 Disintegrin and metalloproteinase domain-containing protein 11 Human genes 0.000 description 2
• 102100031112 Disintegrin and metalloproteinase domain-containing protein 12 Human genes 0.000 description 2
• 102100024692 Double-stranded RNA-specific editase B2 Human genes 0.000 description 2
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 2
• 101000785401 Drosophila melanogaster Polycomb protein Asx Proteins 0.000 description 2
• 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 2
• 102100029951 Estrogen receptor beta Human genes 0.000 description 2
• HKVAMNSJSFKALM-GKUWKFKPSA-N Everolimus Chemical compound C1C[C@@H](OCCO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 HKVAMNSJSFKALM-GKUWKFKPSA-N 0.000 description 2
• 108010067715 Focal Adhesion Protein-Tyrosine Kinases Proteins 0.000 description 2
• 102000016621 Focal Adhesion Protein-Tyrosine Kinases Human genes 0.000 description 2
• 102100024016 G patch domain and ankyrin repeat-containing protein 1 Human genes 0.000 description 2
• 208000032612 Glial tumor Diseases 0.000 description 2
• 206010018338 Glioma Diseases 0.000 description 2
• 102100025376 Glycerol-3-phosphate acyltransferase 4 Human genes 0.000 description 2
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 2
• 101000727994 Homo sapiens ADAMTS-like protein 2 Proteins 0.000 description 2
• 101000701175 Homo sapiens ADAMTS-like protein 3 Proteins 0.000 description 2
• 101000974500 Homo sapiens ADP-ribosylation factor-like protein 1 Proteins 0.000 description 2
• 101000886004 Homo sapiens ADP-ribosylation factor-like protein 3 Proteins 0.000 description 2
• 101000974439 Homo sapiens ADP-ribosylation factor-like protein 5B Proteins 0.000 description 2
• 101000833172 Homo sapiens AF4/FMR2 family member 2 Proteins 0.000 description 2
• 101000717960 Homo sapiens ALS2 C-terminal-like protein Proteins 0.000 description 2
• 101000797458 Homo sapiens AMP deaminase 2 Proteins 0.000 description 2
• 101000806914 Homo sapiens AP-2 complex subunit sigma Proteins 0.000 description 2
• 101000800393 Homo sapiens ATP-binding cassette sub-family G member 4 Proteins 0.000 description 2
• 101000963424 Homo sapiens Acetyl-CoA carboxylase 1 Proteins 0.000 description 2
• 101000677540 Homo sapiens Acetyl-CoA carboxylase 2 Proteins 0.000 description 2
• 101000970954 Homo sapiens Activin receptor type-2A Proteins 0.000 description 2
• 101000720381 Homo sapiens Acyl-coenzyme A thioesterase 8 Proteins 0.000 description 2
• 101000775483 Homo sapiens Adenylate cyclase type 7 Proteins 0.000 description 2
• 101000779572 Homo sapiens Alpha-protein kinase 3 Proteins 0.000 description 2
• 101000891151 Homo sapiens Angiomotin-like protein 2 Proteins 0.000 description 2
• 101000925522 Homo sapiens Ankyrin repeat and SOCS box protein 15 Proteins 0.000 description 2
• 101000754305 Homo sapiens Ankyrin repeat and SOCS box protein 6 Proteins 0.000 description 2
• 101000757210 Homo sapiens Ankyrin repeat domain-containing protein 13D Proteins 0.000 description 2
• 101000780130 Homo sapiens Ankyrin repeat domain-containing protein 29 Proteins 0.000 description 2
• 101000732378 Homo sapiens Ankyrin repeat domain-containing protein 39 Proteins 0.000 description 2
• 101000889428 Homo sapiens Ankyrin repeat domain-containing protein 46 Proteins 0.000 description 2
• 101000925939 Homo sapiens Armadillo repeat-containing X-linked protein 2 Proteins 0.000 description 2
• 101000684964 Homo sapiens Armadillo repeat-containing protein 5 Proteins 0.000 description 2
• 101000685097 Homo sapiens Armadillo repeat-containing protein 6 Proteins 0.000 description 2
• 101000784133 Homo sapiens Arrestin domain-containing protein 4 Proteins 0.000 description 2
• 101000936741 Homo sapiens Astrotactin-1 Proteins 0.000 description 2
• 101000974898 Homo sapiens Ataxin-7-like protein 2 Proteins 0.000 description 2
• 101000785057 Homo sapiens Autophagy-related protein 9A Proteins 0.000 description 2
• 101000785053 Homo sapiens Autophagy-related protein 9B Proteins 0.000 description 2
• 101000971230 Homo sapiens B-cell CLL/lymphoma 7 protein family member A Proteins 0.000 description 2
• 101000798484 Homo sapiens B-cell CLL/lymphoma 7 protein family member B Proteins 0.000 description 2
• 101000971203 Homo sapiens Bcl-2-binding component 3, isoforms 1/2 Proteins 0.000 description 2
• 101000971209 Homo sapiens Bcl-2-binding component 3, isoforms 3/4 Proteins 0.000 description 2
• 101000689619 Homo sapiens Beta-adducin Proteins 0.000 description 2
• 101000677550 Homo sapiens Complex I assembly factor ACAD9, mitochondrial Proteins 0.000 description 2
• 101000936280 Homo sapiens Copper-transporting ATPase 2 Proteins 0.000 description 2
• 101000777452 Homo sapiens Disintegrin and metalloproteinase domain-containing protein 11 Proteins 0.000 description 2
• 101000686486 Homo sapiens Double-stranded RNA-specific editase B2 Proteins 0.000 description 2
• 101000780208 Homo sapiens Long-chain-fatty-acid-CoA ligase 4 Proteins 0.000 description 2
• 101000928479 Homo sapiens Microtubule organization protein AKNA Proteins 0.000 description 2
• 101000775053 Homo sapiens Neuroblast differentiation-associated protein AHNAK Proteins 0.000 description 2
• 101000833913 Homo sapiens Peroxisomal acyl-coenzyme A oxidase 3 Proteins 0.000 description 2
• 101000689394 Homo sapiens Phospholipid scramblase 4 Proteins 0.000 description 2
• 101000728117 Homo sapiens Plasma membrane calcium-transporting ATPase 4 Proteins 0.000 description 2
• 101000887201 Homo sapiens Polyamine-transporting ATPase 13A2 Proteins 0.000 description 2
• 101001066878 Homo sapiens Polyribonucleotide nucleotidyltransferase 1, mitochondrial Proteins 0.000 description 2
• 101000753535 Homo sapiens Potassium-transporting ATPase subunit beta Proteins 0.000 description 2
• 101001068552 Homo sapiens Proline-rich protein 15-like protein Proteins 0.000 description 2
• 101000677831 Homo sapiens Protein ABHD11 Proteins 0.000 description 2
• 101000933604 Homo sapiens Protein BTG2 Proteins 0.000 description 2
• 101001068628 Homo sapiens Protein PRRC2C Proteins 0.000 description 2
• 101000742054 Homo sapiens Protein phosphatase 1D Proteins 0.000 description 2
• 101000798007 Homo sapiens RAC-gamma serine/threonine-protein kinase Proteins 0.000 description 2
• 101001132546 Homo sapiens Ras-related protein Rab-9B Proteins 0.000 description 2
• 101000856728 Homo sapiens Rho GDP-dissociation inhibitor 1 Proteins 0.000 description 2
• 101000927774 Homo sapiens Rho guanine nucleotide exchange factor 12 Proteins 0.000 description 2
• 101000987295 Homo sapiens Serine/threonine-protein kinase PAK 5 Proteins 0.000 description 2
• OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
• 102000000589 Interleukin-1 Human genes 0.000 description 2
• 108010002352 Interleukin-1 Proteins 0.000 description 2
• 102100036600 Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial Human genes 0.000 description 2
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
• 239000005551 L01XE03 - Erlotinib Substances 0.000 description 2
• 239000002147 L01XE04 - Sunitinib Substances 0.000 description 2
• 239000005511 L01XE05 - Sorafenib Substances 0.000 description 2
• 239000002067 L01XE06 - Dasatinib Substances 0.000 description 2
• 239000002136 L01XE07 - Lapatinib Substances 0.000 description 2
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
• 102000003960 Ligases Human genes 0.000 description 2
• 108090000364 Ligases Proteins 0.000 description 2
• 206010024612 Lipoma Diseases 0.000 description 2
• 102100034319 Long-chain-fatty-acid-CoA ligase 4 Human genes 0.000 description 2
• 102100033562 Long-chain-fatty-acid-CoA ligase ACSBG2 Human genes 0.000 description 2
• 102100035699 Lysosomal acid phosphatase Human genes 0.000 description 2
• 102100036470 Microtubule organization protein AKNA Human genes 0.000 description 2
• 108091027766 Mir-143 Proteins 0.000 description 2
• 108091080933 Mir-192/215 microRNA precursor Proteins 0.000 description 2
• 101710151805 Mitochondrial intermediate peptidase 1 Proteins 0.000 description 2
• 229930192392 Mitomycin Natural products 0.000 description 2
• NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
• 102100031837 Neuroblast differentiation-associated protein AHNAK Human genes 0.000 description 2
• 206010029260 Neuroblastoma Diseases 0.000 description 2
• 239000000020 Nitrocellulose Substances 0.000 description 2
• KYRVNWMVYQXFEU-UHFFFAOYSA-N Nocodazole Chemical compound C1=C2NC(NC(=O)OC)=NC2=CC=C1C(=O)C1=CC=CS1 KYRVNWMVYQXFEU-UHFFFAOYSA-N 0.000 description 2
• 101710163270 Nuclease Proteins 0.000 description 2
• 206010061534 Oesophageal squamous cell carcinoma Diseases 0.000 description 2
• 108700020796 Oncogene Proteins 0.000 description 2
• 101100217550 Oryza sativa subsp. indica ATG4B gene Proteins 0.000 description 2
• 206010061535 Ovarian neoplasm Diseases 0.000 description 2
• 102000014160 PTEN Phosphohydrolase Human genes 0.000 description 2
• 108010011536 PTEN Phosphohydrolase Proteins 0.000 description 2
• 102100026777 Peroxisomal acyl-coenzyme A oxidase 3 Human genes 0.000 description 2
• 102100024494 Phospholipid scramblase 4 Human genes 0.000 description 2
• 102100030472 Phospholipid-transporting ATPase IK Human genes 0.000 description 2
• 102000007982 Phosphoproteins Human genes 0.000 description 2
• 108010089430 Phosphoproteins Proteins 0.000 description 2
• OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical group [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
• 102100029743 Plasma membrane calcium-transporting ATPase 4 Human genes 0.000 description 2
• 102100039917 Polyamine-transporting ATPase 13A2 Human genes 0.000 description 2
• 102000002681 Polyribonucleotide nucleotidyltransferase Human genes 0.000 description 2
• 102100021944 Potassium-transporting ATPase subunit beta Human genes 0.000 description 2
• 208000024777 Prion disease Diseases 0.000 description 2
• 102100033950 Proline-rich protein 15-like protein Human genes 0.000 description 2
• 102100034180 Protein AATF Human genes 0.000 description 2
• 102100021499 Protein ABHD11 Human genes 0.000 description 2
• 102100032586 Protein ADM2 Human genes 0.000 description 2
• 102100026034 Protein BTG2 Human genes 0.000 description 2
• 102100033952 Protein PRRC2C Human genes 0.000 description 2
• 102100038675 Protein phosphatase 1D Human genes 0.000 description 2
• 102100032314 RAC-gamma serine/threonine-protein kinase Human genes 0.000 description 2
• 108010016790 RNA-Induced Silencing Complex Proteins 0.000 description 2
• 102000000574 RNA-Induced Silencing Complex Human genes 0.000 description 2
• 102100033965 Ras-related protein Rab-9B Human genes 0.000 description 2
• 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 2
• 102100025619 Rho GDP-dissociation inhibitor 3 Human genes 0.000 description 2
• 102100027663 Rho GTPase-activating protein 12 Human genes 0.000 description 2
• 102100027655 Rho GTPase-activating protein 18 Human genes 0.000 description 2
• 102100035751 Rho GTPase-activating protein 20 Human genes 0.000 description 2
• 102100020894 Rho GTPase-activating protein 27 Human genes 0.000 description 2
• 102100020896 Rho GTPase-activating protein 28 Human genes 0.000 description 2
• 102100021431 Rho GTPase-activating protein 4 Human genes 0.000 description 2
• 102100033193 Rho guanine nucleotide exchange factor 12 Human genes 0.000 description 2
• 102100021709 Rho guanine nucleotide exchange factor 4 Human genes 0.000 description 2
• 102100021688 Rho guanine nucleotide exchange factor 5 Human genes 0.000 description 2
• 102000006382 Ribonucleases Human genes 0.000 description 2
• 108010083644 Ribonucleases Proteins 0.000 description 2
• 230000018199 S phase Effects 0.000 description 2
• 206010070834 Sensitisation Diseases 0.000 description 2
• 102100027941 Serine/threonine-protein kinase PAK 5 Human genes 0.000 description 2
• 208000036765 Squamous cell carcinoma of the esophagus Diseases 0.000 description 2
• 108010017842 Telomerase Proteins 0.000 description 2
• CBPNZQVSJQDFBE-FUXHJELOSA-N Temsirolimus Chemical compound C1C[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 CBPNZQVSJQDFBE-FUXHJELOSA-N 0.000 description 2
• 102100028526 Testicular acid phosphatase Human genes 0.000 description 2
• MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
• 206010070863 Toxicity to various agents Diseases 0.000 description 2
• IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 description 2
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
• 229910052770 Uranium Inorganic materials 0.000 description 2
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
• 102100022748 Wilms tumor protein Human genes 0.000 description 2
• 102100024389 Zinc finger protein AEBP2 Human genes 0.000 description 2
• 238000010521 absorption reaction Methods 0.000 description 2
• DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
• RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 2
• OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
• 230000002411 adverse Effects 0.000 description 2
• 125000003277 amino group Chemical group 0.000 description 2
• VJZITPJGSQKZMX-XDPRQOKASA-N amrubicin Chemical compound O([C@H]1C[C@](CC2=C(O)C=3C(=O)C4=CC=CC=C4C(=O)C=3C(O)=C21)(N)C(=O)C)[C@H]1C[C@H](O)[C@H](O)CO1 VJZITPJGSQKZMX-XDPRQOKASA-N 0.000 description 2
• 229960002550 amrubicin Drugs 0.000 description 2
• 230000000844 anti-bacterial effect Effects 0.000 description 2
• 230000001093 anti-cancer Effects 0.000 description 2
• 239000003429 antifungal agent Substances 0.000 description 2
• 229940121375 antifungal agent Drugs 0.000 description 2
• 230000001640 apoptogenic effect Effects 0.000 description 2
• 239000012736 aqueous medium Substances 0.000 description 2
• VSRXQHXAPYXROS-UHFFFAOYSA-N azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) Chemical compound [NH2-].[NH2-].[Pt+2].OC(=O)C1(C(O)=O)CCC1 VSRXQHXAPYXROS-UHFFFAOYSA-N 0.000 description 2
• 239000002585 base Substances 0.000 description 2
• 239000011230 binding agent Substances 0.000 description 2
• 108091008324 binding proteins Proteins 0.000 description 2
• 210000001124 body fluid Anatomy 0.000 description 2
• GXJABQQUPOEUTA-RDJZCZTQSA-N bortezomib Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)B(O)O)NC(=O)C=1N=CC=NC=1)C1=CC=CC=C1 GXJABQQUPOEUTA-RDJZCZTQSA-N 0.000 description 2
• 229960001467 bortezomib Drugs 0.000 description 2
• 229960004117 capecitabine Drugs 0.000 description 2
• 229960004562 carboplatin Drugs 0.000 description 2
• 230000003197 catalytic effect Effects 0.000 description 2
• 230000032823 cell division Effects 0.000 description 2
• 230000022534 cell killing Effects 0.000 description 2
• 239000013592 cell lysate Substances 0.000 description 2
• 230000003833 cell viability Effects 0.000 description 2
• 230000023715 cellular developmental process Effects 0.000 description 2
• 230000033077 cellular process Effects 0.000 description 2
• 238000012512 characterization method Methods 0.000 description 2
• 125000003636 chemical group Chemical group 0.000 description 2
• 229940044683 chemotherapy drug Drugs 0.000 description 2
• OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
• 210000000349 chromosome Anatomy 0.000 description 2
• 208000024207 chronic leukemia Diseases 0.000 description 2
• 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 2
• 238000000576 coating method Methods 0.000 description 2
• 238000002648 combination therapy Methods 0.000 description 2
• 238000011284 combination treatment Methods 0.000 description 2
• 230000002596 correlated effect Effects 0.000 description 2
• ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
• 229940095074 cyclic amp Drugs 0.000 description 2
• 229940104302 cytosine Drugs 0.000 description 2
• 230000001086 cytosolic effect Effects 0.000 description 2
• 239000000824 cytostatic agent Substances 0.000 description 2
• 230000001085 cytostatic effect Effects 0.000 description 2
• 231100000433 cytotoxic Toxicity 0.000 description 2
• 229960000640 dactinomycin Drugs 0.000 description 2
• 229960002448 dasatinib Drugs 0.000 description 2
• STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 2
• 229960000975 daunorubicin Drugs 0.000 description 2
• 230000034994 death Effects 0.000 description 2
• 238000012217 deletion Methods 0.000 description 2
• 230000037430 deletion Effects 0.000 description 2
• 238000001514 detection method Methods 0.000 description 2
• UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 2
• 229960003957 dexamethasone Drugs 0.000 description 2
• 239000003085 diluting agent Substances 0.000 description 2
• 208000037765 diseases and disorders Diseases 0.000 description 2
• 239000002612 dispersion medium Substances 0.000 description 2
• 238000002651 drug therapy Methods 0.000 description 2
• 229940121647 egfr inhibitor Drugs 0.000 description 2
• 230000008030 elimination Effects 0.000 description 2
• 238000003379 elimination reaction Methods 0.000 description 2
• 150000002118 epoxides Chemical class 0.000 description 2
• 229960001433 erlotinib Drugs 0.000 description 2
• AAKJLRGGTJKAMG-UHFFFAOYSA-N erlotinib Chemical compound C=12C=C(OCCOC)C(OCCOC)=CC2=NC=NC=1NC1=CC=CC(C#C)=C1 AAKJLRGGTJKAMG-UHFFFAOYSA-N 0.000 description 2
• 208000007276 esophageal squamous cell carcinoma Diseases 0.000 description 2
• 229960005420 etoposide Drugs 0.000 description 2
• 229960005167 everolimus Drugs 0.000 description 2
• 230000001747 exhibiting effect Effects 0.000 description 2
• 239000000835 fiber Substances 0.000 description 2
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
• 230000004927 fusion Effects 0.000 description 2
• 210000003976 gap junction Anatomy 0.000 description 2
• 229960000578 gemtuzumab Drugs 0.000 description 2
• LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 2
• 210000003128 head Anatomy 0.000 description 2
• 230000036541 health Effects 0.000 description 2
• 238000010438 heat treatment Methods 0.000 description 2
• 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
• 229940088597 hormone Drugs 0.000 description 2
• 239000005556 hormone Substances 0.000 description 2
• 238000001794 hormone therapy Methods 0.000 description 2
• 229910052739 hydrogen Inorganic materials 0.000 description 2
• 239000001257 hydrogen Substances 0.000 description 2
• FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
• 229960003685 imatinib mesylate Drugs 0.000 description 2
• YLMAHDNUQAMNNX-UHFFFAOYSA-N imatinib methanesulfonate Chemical compound CS(O)(=O)=O.C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 YLMAHDNUQAMNNX-UHFFFAOYSA-N 0.000 description 2
• 230000002519 immonomodulatory effect Effects 0.000 description 2
• 239000012642 immune effector Substances 0.000 description 2
• 238000003364 immunohistochemistry Methods 0.000 description 2
• 229940121354 immunomodulator Drugs 0.000 description 2
• 230000006872 improvement Effects 0.000 description 2
• 239000000411 inducer Substances 0.000 description 2
• 238000001802 infusion Methods 0.000 description 2
• 230000003993 interaction Effects 0.000 description 2
• 230000002452 interceptive effect Effects 0.000 description 2
• 238000007912 intraperitoneal administration Methods 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• 230000005865 ionizing radiation Effects 0.000 description 2
• 239000007951 isotonicity adjuster Substances 0.000 description 2
• 229960004891 lapatinib Drugs 0.000 description 2
• BCFGMOOMADDAQU-UHFFFAOYSA-N lapatinib Chemical compound O1C(CNCCS(=O)(=O)C)=CC=C1C1=CC=C(N=CN=C2NC=3C=C(Cl)C(OCC=4C=C(F)C=CC=4)=CC=3)C2=C1 BCFGMOOMADDAQU-UHFFFAOYSA-N 0.000 description 2
• 229950005692 larotaxel Drugs 0.000 description 2
• SEFGUGYLLVNFIJ-QDRLFVHASA-N larotaxel dihydrate Chemical compound O.O.O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@@]23[C@H]1[C@@]1(CO[C@@H]1C[C@@H]2C3)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 SEFGUGYLLVNFIJ-QDRLFVHASA-N 0.000 description 2
• 239000004816 latex Substances 0.000 description 2
• 229920000126 latex Polymers 0.000 description 2
• 150000002632 lipids Chemical class 0.000 description 2
• 239000006193 liquid solution Substances 0.000 description 2
• 238000012423 maintenance Methods 0.000 description 2
• 230000003211 malignant effect Effects 0.000 description 2
• 238000004949 mass spectrometry Methods 0.000 description 2
• 206010061289 metastatic neoplasm Diseases 0.000 description 2
• 108091056924 miR-124 stem-loop Proteins 0.000 description 2
• 108091074057 miR-16-1 stem-loop Proteins 0.000 description 2
• 108091087148 miR-20 stem-loop Proteins 0.000 description 2
• 108091066984 miR-20-1 stem-loop Proteins 0.000 description 2
• 108091076199 miR-20-2 stem-loop Proteins 0.000 description 2
• 108091088730 miR-215 stem-loop Proteins 0.000 description 2
• 108091059105 miR-216-1 stem-loop Proteins 0.000 description 2
• 108091045470 miR-216-2 stem-loop Proteins 0.000 description 2
• 108091046553 miR-26 stem-loop Proteins 0.000 description 2
• 108091023821 miR-26-1 stem-loop Proteins 0.000 description 2
• 108091045094 miR-26-2 stem-loop Proteins 0.000 description 2
• 108091091696 miR-331 stem-loop Proteins 0.000 description 2
• 238000000386 microscopy Methods 0.000 description 2
• 230000003278 mimic effect Effects 0.000 description 2
• 229960004857 mitomycin Drugs 0.000 description 2
• 230000011278 mitosis Effects 0.000 description 2
• 238000012544 monitoring process Methods 0.000 description 2
• 229940086322 navelbine Drugs 0.000 description 2
• 229920001220 nitrocellulos Polymers 0.000 description 2
• 229950006344 nocodazole Drugs 0.000 description 2
• 230000008520 organization Effects 0.000 description 2
• 201000008968 osteosarcoma Diseases 0.000 description 2
• 210000001672 ovary Anatomy 0.000 description 2
• 229960001756 oxaliplatin Drugs 0.000 description 2
• DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 description 2
• 108700042657 p16 Genes Proteins 0.000 description 2
• 238000007911 parenteral administration Methods 0.000 description 2
• 239000002245 particle Substances 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
• 230000004962 physiological condition Effects 0.000 description 2
• 230000001766 physiological effect Effects 0.000 description 2
• 239000004033 plastic Substances 0.000 description 2
• 229920003023 plastic Polymers 0.000 description 2
• 229920001184 polypeptide Polymers 0.000 description 2
• 239000013641 positive control Substances 0.000 description 2
• CPTBDICYNRMXFX-UHFFFAOYSA-N procarbazine Chemical compound CNNCC1=CC=C(C(=O)NC(C)C)C=C1 CPTBDICYNRMXFX-UHFFFAOYSA-N 0.000 description 2
• 229960000624 procarbazine Drugs 0.000 description 2
• 108090000765 processed proteins & peptides Proteins 0.000 description 2
• 102000004196 processed proteins & peptides Human genes 0.000 description 2
• GZUITABIAKMVPG-UHFFFAOYSA-N raloxifene Chemical compound C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 GZUITABIAKMVPG-UHFFFAOYSA-N 0.000 description 2
• 229960004622 raloxifene Drugs 0.000 description 2
• ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 2
• 239000011535 reaction buffer Substances 0.000 description 2
• 238000003753 real-time PCR Methods 0.000 description 2
• 108700015048 receptor decoy activity proteins Proteins 0.000 description 2
• 230000002441 reversible effect Effects 0.000 description 2
• 230000008313 sensitization Effects 0.000 description 2
• 238000000926 separation method Methods 0.000 description 2
• 229960002930 sirolimus Drugs 0.000 description 2
• QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 2
• 239000011780 sodium chloride Substances 0.000 description 2
• 229960003787 sorafenib Drugs 0.000 description 2
• 238000004611 spectroscopical analysis Methods 0.000 description 2
• 238000010561 standard procedure Methods 0.000 description 2
• 238000003860 storage Methods 0.000 description 2
• WINHZLLDWRZWRT-ATVHPVEESA-N sunitinib Chemical compound CCN(CC)CCNC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C WINHZLLDWRZWRT-ATVHPVEESA-N 0.000 description 2
• 229960001796 sunitinib Drugs 0.000 description 2
• 239000004094 surface-active agent Substances 0.000 description 2
• 238000011477 surgical intervention Methods 0.000 description 2
• 238000007910 systemic administration Methods 0.000 description 2
• 230000009885 systemic effect Effects 0.000 description 2
• 229960001603 tamoxifen Drugs 0.000 description 2
• 229960000235 temsirolimus Drugs 0.000 description 2
• QFJCIRLUMZQUOT-UHFFFAOYSA-N temsirolimus Natural products C1CC(O)C(OC)CC1CC(C)C1OC(=O)C2CCCCN2C(=O)C(=O)C(O)(O2)C(C)CCC2CC(OC)C(C)=CC=CC=CC(C)CC(C)C(=O)C(OC)C(O)C(C)=CC(C)C(=O)C1 QFJCIRLUMZQUOT-UHFFFAOYSA-N 0.000 description 2
• 238000012360 testing method Methods 0.000 description 2
• ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 2
• 229940126585 therapeutic drug Drugs 0.000 description 2
• 150000003573 thiols Chemical class 0.000 description 2
• RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
• 239000003053 toxin Substances 0.000 description 2
• 231100000765 toxin Toxicity 0.000 description 2
• 108700012359 toxins Proteins 0.000 description 2
• 206010044412 transitional cell carcinoma Diseases 0.000 description 2
• 238000011269 treatment regimen Methods 0.000 description 2
• 239000001226 triphosphate Substances 0.000 description 2
• 235000011178 triphosphate Nutrition 0.000 description 2
• 230000003827 upregulation Effects 0.000 description 2
• 208000023747 urothelial carcinoma Diseases 0.000 description 2
• JXLYSJRDGCGARV-CFWMRBGOSA-N vinblastine Chemical compound C([C@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-CFWMRBGOSA-N 0.000 description 2
• CILBMBUYJCWATM-PYGJLNRPSA-N vinorelbine ditartrate Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.OC(=O)[C@H](O)[C@@H](O)C(O)=O.C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC([C@]23[C@H]([C@@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC CILBMBUYJCWATM-PYGJLNRPSA-N 0.000 description 2
• 230000003442 weekly effect Effects 0.000 description 2
• HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
• QGKMIGUHVLGJBR-UHFFFAOYSA-M (4z)-1-(3-methylbutyl)-4-[[1-(3-methylbutyl)quinolin-1-ium-4-yl]methylidene]quinoline;iodide Chemical compound [I-].C12=CC=CC=C2N(CCC(C)C)C=CC1=CC1=CC=[N+](CCC(C)C)C2=CC=CC=C12 QGKMIGUHVLGJBR-UHFFFAOYSA-M 0.000 description 1
• FDKXTQMXEQVLRF-ZHACJKMWSA-N (E)-dacarbazine Chemical compound CN(C)\N=N\c1[nH]cnc1C(N)=O FDKXTQMXEQVLRF-ZHACJKMWSA-N 0.000 description 1
• HWFKCAFKXZFOQT-UHFFFAOYSA-N 1-(3,6-dibromocarbazol-9-yl)-3-piperazin-1-ylpropan-2-ol;dihydrochloride Chemical compound Cl.Cl.C12=CC=C(Br)C=C2C2=CC(Br)=CC=C2N1CC(O)CN1CCNCC1 HWFKCAFKXZFOQT-UHFFFAOYSA-N 0.000 description 1
• 102100038369 1-acyl-sn-glycerol-3-phosphate acyltransferase beta Human genes 0.000 description 1
• 102100030471 1-acyl-sn-glycerol-3-phosphate acyltransferase delta Human genes 0.000 description 1
• 102100026152 1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon Human genes 0.000 description 1
• IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
• WYDKPTZGVLTYPG-UHFFFAOYSA-N 2,8-diamino-3,7-dihydropurin-6-one Chemical compound N1C(N)=NC(=O)C2=C1N=C(N)N2 WYDKPTZGVLTYPG-UHFFFAOYSA-N 0.000 description 1
• RTQWWZBSTRGEAV-PKHIMPSTSA-N 2-[[(2s)-2-[bis(carboxymethyl)amino]-3-[4-(methylcarbamoylamino)phenyl]propyl]-[2-[bis(carboxymethyl)amino]propyl]amino]acetic acid Chemical compound CNC(=O)NC1=CC=C(C[C@@H](CN(CC(C)N(CC(O)=O)CC(O)=O)CC(O)=O)N(CC(O)=O)CC(O)=O)C=C1 RTQWWZBSTRGEAV-PKHIMPSTSA-N 0.000 description 1
• CRYCZDRIXVHNQB-UHFFFAOYSA-N 2-amino-8-bromo-3,7-dihydropurin-6-one Chemical compound N1C(N)=NC(=O)C2=C1N=C(Br)N2 CRYCZDRIXVHNQB-UHFFFAOYSA-N 0.000 description 1
• YCFWZXAEOXKNHL-UHFFFAOYSA-N 2-amino-8-chloro-3,7-dihydropurin-6-one Chemical compound N1C(N)=NC(=O)C2=C1N=C(Cl)N2 YCFWZXAEOXKNHL-UHFFFAOYSA-N 0.000 description 1
• DJGMEMUXTWZGIC-UHFFFAOYSA-N 2-amino-8-methyl-3,7-dihydropurin-6-one Chemical compound N1C(N)=NC(=O)C2=C1N=C(C)N2 DJGMEMUXTWZGIC-UHFFFAOYSA-N 0.000 description 1
• 108010089689 2-aminoadipate transaminase Proteins 0.000 description 1
• MWBWWFOAEOYUST-UHFFFAOYSA-N 2-aminopurine Chemical compound NC1=NC=C2N=CNC2=N1 MWBWWFOAEOYUST-UHFFFAOYSA-N 0.000 description 1
• MEOVPKDOYAIVHZ-UHFFFAOYSA-N 2-chloro-1-(1-methylpyrrol-2-yl)ethanol Chemical compound CN1C=CC=C1C(O)CCl MEOVPKDOYAIVHZ-UHFFFAOYSA-N 0.000 description 1
• ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
• SMADWRYCYBUIKH-UHFFFAOYSA-N 2-methyl-7h-purin-6-amine Chemical compound CC1=NC(N)=C2NC=NC2=N1 SMADWRYCYBUIKH-UHFFFAOYSA-N 0.000 description 1
• FXGXEFXCWDTSQK-UHFFFAOYSA-N 2-methylsulfanyl-7h-purin-6-amine Chemical compound CSC1=NC(N)=C2NC=NC2=N1 FXGXEFXCWDTSQK-UHFFFAOYSA-N 0.000 description 1
• UPGQPDVTCACHAI-UHFFFAOYSA-N 3-(pyridin-2-yldisulfanyl)propanamide Chemical compound NC(=O)CCSSC1=CC=CC=N1 UPGQPDVTCACHAI-UHFFFAOYSA-N 0.000 description 1
• QWZHDKGQKYEBKK-UHFFFAOYSA-N 3-aminochromen-2-one Chemical compound C1=CC=C2OC(=O)C(N)=CC2=C1 QWZHDKGQKYEBKK-UHFFFAOYSA-N 0.000 description 1
• 101710195123 3-hydroxybutyrate dehydrogenase type 2 Proteins 0.000 description 1
• 102100039217 3-ketoacyl-CoA thiolase, peroxisomal Human genes 0.000 description 1
• 125000002103 4,4'-dimethoxytriphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)(C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H])C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 1
• IHDBZCJYSHDCKF-UHFFFAOYSA-N 4,6-dichlorotriazine Chemical compound ClC1=CC(Cl)=NN=N1 IHDBZCJYSHDCKF-UHFFFAOYSA-N 0.000 description 1
• 101710094518 4-aminobutyrate aminotransferase Proteins 0.000 description 1
• 102100026726 40S ribosomal protein S11 Human genes 0.000 description 1
• PTDZLXBJOJLWKG-UHFFFAOYSA-N 5-(bromomethyl)-1h-pyrimidine-2,4-dione Chemical compound BrCC1=CNC(=O)NC1=O PTDZLXBJOJLWKG-UHFFFAOYSA-N 0.000 description 1
• LQLQRFGHAALLLE-UHFFFAOYSA-N 5-bromouracil Chemical compound BrC1=CNC(=O)NC1=O LQLQRFGHAALLLE-UHFFFAOYSA-N 0.000 description 1
• ORLGPUVJERIKLW-UHFFFAOYSA-N 5-chlorotriazine Chemical compound ClC1=CN=NN=C1 ORLGPUVJERIKLW-UHFFFAOYSA-N 0.000 description 1
• ZFTBZKVVGZNMJR-UHFFFAOYSA-N 5-chlorouracil Chemical compound ClC1=CNC(=O)NC1=O ZFTBZKVVGZNMJR-UHFFFAOYSA-N 0.000 description 1
• RHIULBJJKFDJPR-UHFFFAOYSA-N 5-ethyl-1h-pyrimidine-2,4-dione Chemical compound CCC1=CNC(=O)NC1=O RHIULBJJKFDJPR-UHFFFAOYSA-N 0.000 description 1
• KSNXJLQDQOIRIP-UHFFFAOYSA-N 5-iodouracil Chemical compound IC1=CNC(=O)NC1=O KSNXJLQDQOIRIP-UHFFFAOYSA-N 0.000 description 1
• JHEKLAXXCHLMNM-UHFFFAOYSA-N 5-propyl-1h-pyrimidine-2,4-dione Chemical compound CCCC1=CNC(=O)NC1=O JHEKLAXXCHLMNM-UHFFFAOYSA-N 0.000 description 1
• CZJGCEGNCSGRBI-UHFFFAOYSA-N 6-amino-5-ethyl-1h-pyrimidin-2-one Chemical compound CCC1=CNC(=O)N=C1N CZJGCEGNCSGRBI-UHFFFAOYSA-N 0.000 description 1
• IDLISIVVYLGCKO-UHFFFAOYSA-N 6-carboxy-4',5'-dichloro-2',7'-dimethoxyfluorescein Chemical compound O1C(=O)C2=CC=C(C(O)=O)C=C2C21C1=CC(OC)=C(O)C(Cl)=C1OC1=C2C=C(OC)C(O)=C1Cl IDLISIVVYLGCKO-UHFFFAOYSA-N 0.000 description 1
• BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 1
• 102100031854 60S ribosomal protein L14 Human genes 0.000 description 1
• 102100030982 60S ribosomal protein L38 Human genes 0.000 description 1
• CLGFIVUFZRGQRP-UHFFFAOYSA-N 7,8-dihydro-8-oxoguanine Chemical compound O=C1NC(N)=NC2=C1NC(=O)N2 CLGFIVUFZRGQRP-UHFFFAOYSA-N 0.000 description 1
• LPXQRXLUHJKZIE-UHFFFAOYSA-N 8-azaguanine Chemical compound NC1=NC(O)=C2NN=NC2=N1 LPXQRXLUHJKZIE-UHFFFAOYSA-N 0.000 description 1
• FVXHPCVBOXMRJP-UHFFFAOYSA-N 8-bromo-7h-purin-6-amine Chemical compound NC1=NC=NC2=C1NC(Br)=N2 FVXHPCVBOXMRJP-UHFFFAOYSA-N 0.000 description 1
• RGKBRPAAQSHTED-UHFFFAOYSA-N 8-oxoadenine Chemical compound NC1=NC=NC2=C1NC(=O)N2 RGKBRPAAQSHTED-UHFFFAOYSA-N 0.000 description 1
• MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 1
• 108010011122 A Kinase Anchor Proteins Proteins 0.000 description 1
• 102000014022 A Kinase Anchor Proteins Human genes 0.000 description 1
• 102100032290 A disintegrin and metalloproteinase with thrombospondin motifs 13 Human genes 0.000 description 1
• 102100032293 A disintegrin and metalloproteinase with thrombospondin motifs 18 Human genes 0.000 description 1
• 102100027401 A disintegrin and metalloproteinase with thrombospondin motifs 3 Human genes 0.000 description 1
• 102100027400 A disintegrin and metalloproteinase with thrombospondin motifs 4 Human genes 0.000 description 1
• 102100032632 A disintegrin and metalloproteinase with thrombospondin motifs 6 Human genes 0.000 description 1
• 102100033811 A-kinase anchor protein 11 Human genes 0.000 description 1
• 101710170215 A-kinase anchor protein 11 Proteins 0.000 description 1
• 102100033824 A-kinase anchor protein 12 Human genes 0.000 description 1
• 102300049325 A-kinase anchor protein 12 isoform 1 Human genes 0.000 description 1
• 102100024049 A-kinase anchor protein 13 Human genes 0.000 description 1
• 102300043138 A-kinase anchor protein 13 isoform 1 Human genes 0.000 description 1
• 101150020052 AADAT gene Proteins 0.000 description 1
• 102100028281 ABC-type oligopeptide transporter ABCB9 Human genes 0.000 description 1
• 108091007507 ADAM12 Proteins 0.000 description 1
• 102100029769 ADAMTS-like protein 1 Human genes 0.000 description 1
• 108091005670 ADAMTS13 Proteins 0.000 description 1
• 108091005568 ADAMTS18 Proteins 0.000 description 1
• 108091005661 ADAMTS3 Proteins 0.000 description 1
• 108091005664 ADAMTS4 Proteins 0.000 description 1
• 108091005663 ADAMTS5 Proteins 0.000 description 1
• 102000051389 ADAMTS5 Human genes 0.000 description 1
• 108091005665 ADAMTS6 Proteins 0.000 description 1
• 102000020236 ADP-ribosylarginine hydrolase Human genes 0.000 description 1
• 108010079768 ADP-ribosylarginine hydrolase Proteins 0.000 description 1
• 101710139744 ADP-ribosylation factor 3 Proteins 0.000 description 1
• 108010053423 ADP-ribosylation factor related proteins Proteins 0.000 description 1
• 102100028468 ADP-ribosylation factor-like protein 10 Human genes 0.000 description 1
• 102100023961 ADP-ribosylation factor-like protein 2-binding protein Human genes 0.000 description 1
• 102100028357 ADP-ribosylation factor-like protein 8B Human genes 0.000 description 1
• 102100034119 ADP-ribosylhydrolase ARH1 Human genes 0.000 description 1
• 102000017906 ADRA2A Human genes 0.000 description 1
• 102100024381 AF4/FMR2 family member 4 Human genes 0.000 description 1
• 101150079978 AGRN gene Proteins 0.000 description 1
• 102000010553 ALAD Human genes 0.000 description 1
• 101150082527 ALAD gene Proteins 0.000 description 1
• 102000011814 AMMECR1 Human genes 0.000 description 1
• 108050002283 AMMECR1 Proteins 0.000 description 1
• 102100032898 AMP deaminase 3 Human genes 0.000 description 1
• 102100033938 AP-1 complex subunit gamma-1 Human genes 0.000 description 1
• 102100028777 AP-1 complex subunit sigma-1A Human genes 0.000 description 1
• 102100022974 AP-2 complex subunit alpha-2 Human genes 0.000 description 1
• 102100033936 AP-3 complex subunit beta-1 Human genes 0.000 description 1
• 102100040005 AP-3 complex subunit mu-1 Human genes 0.000 description 1
• 102100028783 AP-3 complex subunit sigma-2 Human genes 0.000 description 1
• 108010079649 APOBEC-1 Deaminase Proteins 0.000 description 1
• 102000012758 APOBEC-1 Deaminase Human genes 0.000 description 1
• 101150107820 ATG9 gene Proteins 0.000 description 1
• 102100021921 ATP synthase subunit a Human genes 0.000 description 1
• 102100021501 ATP-binding cassette sub-family B member 5 Human genes 0.000 description 1
• 102100021503 ATP-binding cassette sub-family B member 6 Human genes 0.000 description 1
• 102100037128 ATP-binding cassette sub-family C member 10 Human genes 0.000 description 1
• 102100028162 ATP-binding cassette sub-family C member 3 Human genes 0.000 description 1
• 102100028186 ATP-binding cassette sub-family C member 5 Human genes 0.000 description 1
• 102100022654 ATP-binding cassette sub-family F member 2 Human genes 0.000 description 1
• 102100022655 ATP-binding cassette sub-family F member 3 Human genes 0.000 description 1
• 102100022936 ATPase inhibitor, mitochondrial Human genes 0.000 description 1
• 240000005020 Acaciella glauca Species 0.000 description 1
• 101710194784 Acetyl-coenzyme A synthetase, cytoplasmic Proteins 0.000 description 1
• 102100022144 Achaete-scute homolog 2 Human genes 0.000 description 1
• 101710099897 Acid-sensing ion channel 4 Proteins 0.000 description 1
• 102100033404 Acidic leucine-rich nuclear phosphoprotein 32 family member E Human genes 0.000 description 1
• 101000787132 Acidithiobacillus ferridurans Uncharacterized 8.2 kDa protein in mobL 3'region Proteins 0.000 description 1
• 101000827262 Acidithiobacillus ferrooxidans Uncharacterized 18.9 kDa protein in mobE 3'region Proteins 0.000 description 1
• 102100020963 Actin-binding LIM protein 1 Human genes 0.000 description 1
• 101710123570 Actin-binding LIM protein 1 Proteins 0.000 description 1
• 102000009185 Actin-filament associated proteins Human genes 0.000 description 1
• 108050000056 Actin-filament associated proteins Proteins 0.000 description 1
• 102100038820 Actin-related protein 2/3 complex subunit 1B Human genes 0.000 description 1
• 108050000119 Actin-related protein 2/3 complex subunit 1B Proteins 0.000 description 1
• 102100029631 Actin-related protein 3B Human genes 0.000 description 1
• 101710126744 Actin-related protein 8 Proteins 0.000 description 1
• 108010085371 Activating Transcription Factor 3 Proteins 0.000 description 1
• 108010085405 Activating Transcription Factor 6 Proteins 0.000 description 1
• 102100028100 Activating signal cointegrator 1 Human genes 0.000 description 1
• 101710089542 Activating signal cointegrator 1 Proteins 0.000 description 1
• 102100021029 Activating signal cointegrator 1 complex subunit 3 Human genes 0.000 description 1
• 102100030865 Activating transcription factor 7-interacting protein 2 Human genes 0.000 description 1
• 102100032382 Activator of 90 kDa heat shock protein ATPase homolog 1 Human genes 0.000 description 1
• 101710162400 Activator of 90 kDa heat shock protein ATPase homolog 1 Proteins 0.000 description 1
• 102000004539 Acyl-CoA Oxidase Human genes 0.000 description 1
• 108020001558 Acyl-CoA oxidase Proteins 0.000 description 1
• 102100033757 Acyl-coenzyme A thioesterase 11 Human genes 0.000 description 1
• 229930024421 Adenine Natural products 0.000 description 1
• GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
• 102100034540 Adenomatous polyposis coli protein Human genes 0.000 description 1
• 102000007471 Adenosine A2A receptor Human genes 0.000 description 1
• 108010085277 Adenosine A2A receptor Proteins 0.000 description 1
• 102100035990 Adenosine receptor A2a Human genes 0.000 description 1
• 102100039677 Adenylate cyclase type 1 Human genes 0.000 description 1
• 102100040439 Adenylate kinase 4, mitochondrial Human genes 0.000 description 1
• 108050004095 Adenylate kinase 4, mitochondrial Proteins 0.000 description 1
• 108010056443 Adenylosuccinate synthase Proteins 0.000 description 1
• 101710096306 Adhesion G protein-coupled receptor B1 Proteins 0.000 description 1
• 101800001511 Adrenomedullin-2 Proteins 0.000 description 1
• 101710149366 Afamin Proteins 0.000 description 1
• 229920000936 Agarose Polymers 0.000 description 1
• 108700019743 Agrin Proteins 0.000 description 1
• 101150044980 Akap1 gene Proteins 0.000 description 1
• 102100026608 Aldehyde dehydrogenase family 3 member A2 Human genes 0.000 description 1
• 102100026609 Aldehyde dehydrogenase family 3 member B1 Human genes 0.000 description 1
• 102100036826 Aldehyde oxidase Human genes 0.000 description 1
• 102000005602 Aldo-Keto Reductases Human genes 0.000 description 1
• 108010084469 Aldo-Keto Reductases Proteins 0.000 description 1
• 102100024086 Aldo-keto reductase family 1 member D1 Human genes 0.000 description 1
• 239000012103 Alexa Fluor 488 Substances 0.000 description 1
• 239000012104 Alexa Fluor 500 Substances 0.000 description 1
• 239000012105 Alexa Fluor 514 Substances 0.000 description 1
• 239000012109 Alexa Fluor 568 Substances 0.000 description 1
• 239000012110 Alexa Fluor 594 Substances 0.000 description 1
• 239000012111 Alexa Fluor 610 Substances 0.000 description 1
• 239000012112 Alexa Fluor 633 Substances 0.000 description 1
• 239000012114 Alexa Fluor 647 Substances 0.000 description 1
• 239000012115 Alexa Fluor 660 Substances 0.000 description 1
• 239000012116 Alexa Fluor 680 Substances 0.000 description 1
• 239000012117 Alexa Fluor 700 Substances 0.000 description 1
• 239000012118 Alexa Fluor 750 Substances 0.000 description 1
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
• 102100025677 Alkaline phosphatase, germ cell type Human genes 0.000 description 1
• 102100036666 Alpha-2B adrenergic receptor Human genes 0.000 description 1
• 102100034033 Alpha-adducin Human genes 0.000 description 1
• 101710101449 Alpha-centractin Proteins 0.000 description 1
• 102100039086 Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 Human genes 0.000 description 1
• 102100040433 Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 Human genes 0.000 description 1
• 101710187109 Alsin Proteins 0.000 description 1
• 108010058065 Aminomethyltransferase Proteins 0.000 description 1
• USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
• 239000005695 Ammonium acetate Substances 0.000 description 1
• 102100031993 Amphoterin-induced protein 3 Human genes 0.000 description 1
• 101710168921 Amyloid beta precursor like protein 2 Proteins 0.000 description 1
• 108010090849 Amyloid beta-Peptides Proteins 0.000 description 1
• 102000013455 Amyloid beta-Peptides Human genes 0.000 description 1
• 102100033972 Amyloid protein-binding protein 2 Human genes 0.000 description 1
• 102100036514 Amyloid-beta A4 precursor protein-binding family A member 1 Human genes 0.000 description 1
• 102100040016 Amyloid-beta A4 precursor protein-binding family B member 3 Human genes 0.000 description 1
• 101710137189 Amyloid-beta A4 protein Proteins 0.000 description 1
• 102100022704 Amyloid-beta precursor protein Human genes 0.000 description 1
• 101710151993 Amyloid-beta precursor protein Proteins 0.000 description 1
• 102000052593 Anaphase-Promoting Complex-Cyclosome Apc11 Subunit Human genes 0.000 description 1
• 101710155999 Anaphase-promoting complex subunit 13 Proteins 0.000 description 1
• 102000043902 Angiomotin Human genes 0.000 description 1
• 108700020509 Angiomotin Proteins 0.000 description 1
• 102100040360 Angiomotin Human genes 0.000 description 1
• 102100040357 Angiomotin-like protein 1 Human genes 0.000 description 1
• 102000008873 Angiotensin II receptor Human genes 0.000 description 1
• 108050000824 Angiotensin II receptor Proteins 0.000 description 1
• 102100040434 Ankyrin repeat and BTB/POZ domain-containing protein 2 Human genes 0.000 description 1
• 102100027150 Ankyrin repeat and SAM domain-containing protein 4B Human genes 0.000 description 1
• 102100034614 Ankyrin repeat domain-containing protein 11 Human genes 0.000 description 1
• 101710188804 Ankyrin repeat domain-containing protein 11 Proteins 0.000 description 1
• 102100034269 Ankyrin repeat domain-containing protein 13B Human genes 0.000 description 1
• 102100039158 Ankyrin repeat domain-containing protein 53 Human genes 0.000 description 1
• 101710191059 Ankyrin-1 Proteins 0.000 description 1
• 101710191052 Ankyrin-2 Proteins 0.000 description 1
• 102100036817 Ankyrin-3 Human genes 0.000 description 1
• 102300042772 Ankyrin-3 isoform 2 Human genes 0.000 description 1
• 102000000412 Annexin Human genes 0.000 description 1
• 108050008874 Annexin Proteins 0.000 description 1
• 108090000668 Annexin A2 Proteins 0.000 description 1
• 101000811747 Antithamnion sp. UPF0051 protein in atpA 3'region Proteins 0.000 description 1
• 102000018746 Apelin Human genes 0.000 description 1
• 108010052412 Apelin Proteins 0.000 description 1
• 102100029459 Apelin Human genes 0.000 description 1
• 102100040197 Apolipoprotein A-V Human genes 0.000 description 1
• 108010061118 Apolipoprotein A-V Proteins 0.000 description 1
• 102100030970 Apolipoprotein C-III Human genes 0.000 description 1
• 102100021893 Apoptosis facilitator Bcl-2-like protein 14 Human genes 0.000 description 1
• 101710105690 Aprataxin Proteins 0.000 description 1
• 102100023650 Aquaporin-11 Human genes 0.000 description 1
• 102000010637 Aquaporins Human genes 0.000 description 1
• 108010063290 Aquaporins Proteins 0.000 description 1
• 102000011730 Arachidonate 12-Lipoxygenase Human genes 0.000 description 1
• 108010076676 Arachidonate 12-lipoxygenase Proteins 0.000 description 1
• 102100031464 Armadillo repeat protein deleted in velo-cardio-facial syndrome Human genes 0.000 description 1
• 102100023180 Armadillo repeat-containing protein 5 Human genes 0.000 description 1
• 241000796533 Arna Species 0.000 description 1
• 102100022143 Arsenite methyltransferase Human genes 0.000 description 1
• 108010049386 Aryl Hydrocarbon Receptor Nuclear Translocator Proteins 0.000 description 1
• 101710115233 Arylsulfatase D Proteins 0.000 description 1
• 102100038063 Asparagine synthetase domain-containing protein 1 Human genes 0.000 description 1
• 101710140787 Aspartyl/asparaginyl beta-hydroxylase Proteins 0.000 description 1
• 108010023546 Aspartylglucosylaminase Proteins 0.000 description 1
• 102100020741 Atrophin-1 Human genes 0.000 description 1
• 108090000806 Atrophin-1 Proteins 0.000 description 1
• 102100027935 Attractin-like protein 1 Human genes 0.000 description 1
• 102000004000 Aurora Kinase A Human genes 0.000 description 1
• 108090000461 Aurora Kinase A Proteins 0.000 description 1
• 101700047552 Axin-2 Proteins 0.000 description 1
• NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
• 108091008875 B cell receptors Proteins 0.000 description 1
• 101710165244 B-cell CLL/lymphoma 9 protein Proteins 0.000 description 1
• 101710130402 B-cell CLL/lymphoma 9-like protein Proteins 0.000 description 1
• 102100038080 B-cell receptor CD22 Human genes 0.000 description 1
• 102100037586 B-cell receptor-associated protein 29 Human genes 0.000 description 1
• 101710113110 B-cell receptor-associated protein 31 Proteins 0.000 description 1
• 101710089791 BAG family molecular chaperone regulator 3 Proteins 0.000 description 1
• 101710089799 BAG family molecular chaperone regulator 4 Proteins 0.000 description 1
• 101710089800 BAG family molecular chaperone regulator 5 Proteins 0.000 description 1
• 102100021256 BCL-6 corepressor-like protein 1 Human genes 0.000 description 1
• 102100028169 BET1-like protein Human genes 0.000 description 1
• 101000827607 Bacillus phage SPP1 Uncharacterized 8.5 kDa protein in GP2-GP6 intergenic region Proteins 0.000 description 1
• 101000961975 Bacillus thuringiensis Uncharacterized 13.4 kDa protein Proteins 0.000 description 1
• 241000894006 Bacteria Species 0.000 description 1
• 102000001765 Bcl-2-Like Protein 11 Human genes 0.000 description 1
• 108010040168 Bcl-2-Like Protein 11 Proteins 0.000 description 1
• 102100021894 Bcl-2-like protein 12 Human genes 0.000 description 1
• 102100023932 Bcl-2-like protein 2 Human genes 0.000 description 1
• 101150017888 Bcl2 gene Proteins 0.000 description 1
• 102100023993 Beta-1,3-galactosyltransferase 5 Human genes 0.000 description 1
• 102100023994 Beta-1,3-galactosyltransferase 6 Human genes 0.000 description 1
• 102100026349 Beta-1,4-galactosyltransferase 1 Human genes 0.000 description 1
• 102100039705 Beta-2 adrenergic receptor Human genes 0.000 description 1
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
• 102100021738 Beta-adrenergic receptor kinase 1 Human genes 0.000 description 1
• 102100021257 Beta-secretase 1 Human genes 0.000 description 1
• 101710150192 Beta-secretase 1 Proteins 0.000 description 1
• 101710150190 Beta-secretase 2 Proteins 0.000 description 1
• 102100027950 Bile acid-CoA:amino acid N-acyltransferase Human genes 0.000 description 1
• 102100037674 Bis(5'-adenosyl)-triphosphatase Human genes 0.000 description 1
• 108050000671 Bradykinin receptor B2 Proteins 0.000 description 1
• 102100026346 Brain-specific angiogenesis inhibitor 1-associated protein 2 Human genes 0.000 description 1
• 101710123266 Breast carcinoma-amplified sequence 1 Proteins 0.000 description 1
• 101710123279 Breast carcinoma-amplified sequence 4 Proteins 0.000 description 1
• 102100027359 Bromo adjacent homology domain-containing 1 protein Human genes 0.000 description 1
• 102100021576 Bromodomain adjacent to zinc finger domain protein 2A Human genes 0.000 description 1
• 102100032367 C-C motif chemokine 5 Human genes 0.000 description 1
• 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
• 102100037080 C4b-binding protein beta chain Human genes 0.000 description 1
• 108700012439 CA9 Proteins 0.000 description 1
• 102100024217 CAMPATH-1 antigen Human genes 0.000 description 1
• 102100031168 CCN family member 2 Human genes 0.000 description 1
• 102100025215 CCN family member 5 Human genes 0.000 description 1
• 101150013553 CD40 gene Proteins 0.000 description 1
• 108010065524 CD52 Antigen Proteins 0.000 description 1
• 108010062802 CD66 antigens Proteins 0.000 description 1
• 102100024152 Cadherin-17 Human genes 0.000 description 1
• 101000690445 Caenorhabditis elegans Aryl hydrocarbon receptor nuclear translocator homolog Proteins 0.000 description 1
• 101000983866 Caenorhabditis elegans Lysophosphatidylinositol acyltransferase 10 Proteins 0.000 description 1
• 101100164114 Caenorhabditis elegans asb-1 gene Proteins 0.000 description 1
• 101000964407 Caldicellulosiruptor saccharolyticus Uncharacterized 10.7 kDa protein in xynB 3'region Proteins 0.000 description 1
• 102100028801 Calsyntenin-1 Human genes 0.000 description 1
• 102100033040 Carbonic anhydrase 12 Human genes 0.000 description 1
• 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 1
• 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 1
• DLGOEMSEDOSKAD-UHFFFAOYSA-N Carmustine Chemical compound ClCCNC(=O)N(N=O)CCCl DLGOEMSEDOSKAD-UHFFFAOYSA-N 0.000 description 1
• 102000011068 Cdc42 Human genes 0.000 description 1
• 108050001278 Cdc42 Proteins 0.000 description 1
• 101710114824 Cell death regulator Aven Proteins 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• 108010055166 Chemokine CCL5 Proteins 0.000 description 1
• 241001227713 Chiron Species 0.000 description 1
• 108010049048 Cholera Toxin Proteins 0.000 description 1
• 102000009016 Cholera Toxin Human genes 0.000 description 1
• 102100026191 Class E basic helix-loop-helix protein 40 Human genes 0.000 description 1
• RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
• 101710202359 Coatomer subunit delta Proteins 0.000 description 1
• UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 1
• 102100033601 Collagen alpha-1(I) chain Human genes 0.000 description 1
• 102100033825 Collagen alpha-1(XI) chain Human genes 0.000 description 1
• 108010039419 Connective Tissue Growth Factor Proteins 0.000 description 1
• 108010022637 Copper-Transporting ATPases Proteins 0.000 description 1
• 102100023032 Cyclic AMP-dependent transcription factor ATF-3 Human genes 0.000 description 1
• 102100023578 Cyclic AMP-dependent transcription factor ATF-7 Human genes 0.000 description 1
• 101710181881 Cyclic AMP-dependent transcription factor ATF-7 Proteins 0.000 description 1
• 102000016736 Cyclin Human genes 0.000 description 1
• 108050006400 Cyclin Proteins 0.000 description 1
• 102000006311 Cyclin D1 Human genes 0.000 description 1
• 108010058546 Cyclin D1 Proteins 0.000 description 1
• 108010025468 Cyclin-Dependent Kinase 6 Proteins 0.000 description 1
• 108010009367 Cyclin-Dependent Kinase Inhibitor p18 Proteins 0.000 description 1
• 102100038250 Cyclin-G2 Human genes 0.000 description 1
• 229940083347 Cyclin-dependent kinase 4 inhibitor Drugs 0.000 description 1
• 102100024465 Cyclin-dependent kinase 4 inhibitor C Human genes 0.000 description 1
• 102100026804 Cyclin-dependent kinase 6 Human genes 0.000 description 1
• 102000003903 Cyclin-dependent kinases Human genes 0.000 description 1
• 108090000266 Cyclin-dependent kinases Proteins 0.000 description 1
• 108010037462 Cyclooxygenase 2 Proteins 0.000 description 1
• 102100021903 Cysteine protease ATG4B Human genes 0.000 description 1
• 102100027713 Cysteine protease ATG4D Human genes 0.000 description 1
• 102100031127 Cysteine/serine-rich nuclear protein 1 Human genes 0.000 description 1
• 102100024916 Cytochrome P450 4F11 Human genes 0.000 description 1
• 102100024901 Cytochrome P450 4F3 Human genes 0.000 description 1
• 101710152190 Cytosolic acyl coenzyme A thioester hydrolase Proteins 0.000 description 1
• 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 description 1
• HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
• 230000033616 DNA repair Effects 0.000 description 1
• 102100028862 Delta-aminolevulinic acid dehydratase Human genes 0.000 description 1
• AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 1
• 229920002307 Dextran Polymers 0.000 description 1
• SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
• VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 1
• 241000275449 Diplectrum formosum Species 0.000 description 1
• 206010061818 Disease progression Diseases 0.000 description 1
• 102100039673 Disintegrin and metalloproteinase domain-containing protein 10 Human genes 0.000 description 1
• 206010059866 Drug resistance Diseases 0.000 description 1
• 102100034597 E3 ubiquitin-protein ligase TRIM22 Human genes 0.000 description 1
• 102100020960 E3 ubiquitin-protein transferase RMND5A Human genes 0.000 description 1
• 102100031814 EGF-containing fibulin-like extracellular matrix protein 1 Human genes 0.000 description 1
• 102100033267 Early placenta insulin-like peptide Human genes 0.000 description 1
• 102100021598 Endoplasmic reticulum aminopeptidase 1 Human genes 0.000 description 1
• 101710168245 Endoplasmic reticulum aminopeptidase 1 Proteins 0.000 description 1
• 102100032460 Ensconsin Human genes 0.000 description 1
• 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
• 108010007457 Extracellular Signal-Regulated MAP Kinases Proteins 0.000 description 1
• 102100020903 Ezrin Human genes 0.000 description 1
• 101150021185 FGF gene Proteins 0.000 description 1
• 108010076282 Factor IX Proteins 0.000 description 1
• 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
• 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
• 102100027844 Fibroblast growth factor receptor 4 Human genes 0.000 description 1
• 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
• 102000010451 Folate receptor alpha Human genes 0.000 description 1
• 108050001931 Folate receptor alpha Proteins 0.000 description 1
• 241000233866 Fungi Species 0.000 description 1
• 101710100337 G patch domain and ankyrin repeat-containing protein 1 Proteins 0.000 description 1
• 108010056715 G-Protein-Coupled Receptor Kinase 2 Proteins 0.000 description 1
• 102000013446 GTP Phosphohydrolases Human genes 0.000 description 1
• 102100027541 GTP-binding protein Rheb Human genes 0.000 description 1
• 108091006109 GTPases Proteins 0.000 description 1
• 102100021260 Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 Human genes 0.000 description 1
• 102100027959 Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 Human genes 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• 230000010558 Gene Alterations Effects 0.000 description 1
• 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 description 1
• 101710199766 Glycerol-3-phosphate acyltransferase 4 Proteins 0.000 description 1
• 102100029880 Glycodelin Human genes 0.000 description 1
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
• XKMLYUALXHKNFT-UUOKFMHZSA-N Guanosine-5'-triphosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XKMLYUALXHKNFT-UUOKFMHZSA-N 0.000 description 1
• 102100035688 Guanylate-binding protein 1 Human genes 0.000 description 1
• 101000768777 Haloferax lucentense (strain DSM 14919 / JCM 9276 / NCIMB 13854 / Aa 2.2) Uncharacterized 50.6 kDa protein in the 5'region of gyrA and gyrB Proteins 0.000 description 1
• 102100037907 High mobility group protein B1 Human genes 0.000 description 1
• 101710168537 High mobility group protein B1 Proteins 0.000 description 1
• 101000605571 Homo sapiens 1-acyl-sn-glycerol-3-phosphate acyltransferase beta Proteins 0.000 description 1
• 101001126450 Homo sapiens 1-acyl-sn-glycerol-3-phosphate acyltransferase delta Proteins 0.000 description 1
• 101000691569 Homo sapiens 1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon Proteins 0.000 description 1
• 101000764864 Homo sapiens 3-hydroxybutyrate dehydrogenase type 2 Proteins 0.000 description 1
• 101000670146 Homo sapiens 3-ketoacyl-CoA thiolase, peroxisomal Proteins 0.000 description 1
• 101001000686 Homo sapiens 4-aminobutyrate aminotransferase, mitochondrial Proteins 0.000 description 1
• 101001119215 Homo sapiens 40S ribosomal protein S11 Proteins 0.000 description 1
• 101000704267 Homo sapiens 60S ribosomal protein L14 Proteins 0.000 description 1
• 101001127039 Homo sapiens 60S ribosomal protein L38 Proteins 0.000 description 1
• 101000779382 Homo sapiens A-kinase anchor protein 12 Proteins 0.000 description 1
• 101000833679 Homo sapiens A-kinase anchor protein 13 Proteins 0.000 description 1
• 101000724357 Homo sapiens ABC-type oligopeptide transporter ABCB9 Proteins 0.000 description 1
• 101000724234 Homo sapiens ABI gene family member 3 Proteins 0.000 description 1
• 101100107640 Homo sapiens ABI3 gene Proteins 0.000 description 1
• 101000727998 Homo sapiens ADAMTS-like protein 1 Proteins 0.000 description 1
• 101000684275 Homo sapiens ADP-ribosylation factor 3 Proteins 0.000 description 1
• 101000769450 Homo sapiens ADP-ribosylation factor-like protein 10 Proteins 0.000 description 1
• 101000757692 Homo sapiens ADP-ribosylation factor-like protein 2-binding protein Proteins 0.000 description 1
• 101000769042 Homo sapiens ADP-ribosylation factor-like protein 8B Proteins 0.000 description 1
• 101000809413 Homo sapiens ADP-ribosylation factor-related protein 1 Proteins 0.000 description 1
• 101000780532 Homo sapiens ADP-ribosylhydrolase ARH1 Proteins 0.000 description 1
• 101000833170 Homo sapiens AF4/FMR2 family member 4 Proteins 0.000 description 1
• 101000797462 Homo sapiens AMP deaminase 3 Proteins 0.000 description 1
• 101000779234 Homo sapiens AP-1 complex subunit gamma-1 Proteins 0.000 description 1
• 101000768000 Homo sapiens AP-1 complex subunit sigma-1A Proteins 0.000 description 1
• 101000757394 Homo sapiens AP-2 complex subunit alpha-2 Proteins 0.000 description 1
• 101000779239 Homo sapiens AP-3 complex subunit beta-1 Proteins 0.000 description 1
• 101000959726 Homo sapiens AP-3 complex subunit mu-1 Proteins 0.000 description 1
• 101000768007 Homo sapiens AP-3 complex subunit sigma-2 Proteins 0.000 description 1
• 101000753741 Homo sapiens ATP synthase subunit a Proteins 0.000 description 1
• 101000677872 Homo sapiens ATP-binding cassette sub-family B member 5 Proteins 0.000 description 1
• 101000677883 Homo sapiens ATP-binding cassette sub-family B member 6 Proteins 0.000 description 1
• 101001029059 Homo sapiens ATP-binding cassette sub-family C member 10 Proteins 0.000 description 1
• 101000986633 Homo sapiens ATP-binding cassette sub-family C member 3 Proteins 0.000 description 1
• 101000986622 Homo sapiens ATP-binding cassette sub-family C member 5 Proteins 0.000 description 1
• 101000823289 Homo sapiens ATP-binding cassette sub-family F member 2 Proteins 0.000 description 1
• 101000823284 Homo sapiens ATP-binding cassette sub-family F member 3 Proteins 0.000 description 1
• 101000902767 Homo sapiens ATPase inhibitor, mitochondrial Proteins 0.000 description 1
• 101000678027 Homo sapiens Acetoacetyl-CoA synthetase Proteins 0.000 description 1
• 101000783232 Homo sapiens Acetyl-coenzyme A synthetase, cytoplasmic Proteins 0.000 description 1
• 101000901109 Homo sapiens Achaete-scute homolog 2 Proteins 0.000 description 1
• 101000901087 Homo sapiens Acid-sensing ion channel 4 Proteins 0.000 description 1
• 101000732665 Homo sapiens Acidic leucine-rich nuclear phosphoprotein 32 family member E Proteins 0.000 description 1
• 101000728742 Homo sapiens Actin-related protein 3B Proteins 0.000 description 1
• 101000688199 Homo sapiens Actin-related protein 8 Proteins 0.000 description 1
• 101000784211 Homo sapiens Activating signal cointegrator 1 complex subunit 3 Proteins 0.000 description 1
• 101000583789 Homo sapiens Activating transcription factor 7-interacting protein 2 Proteins 0.000 description 1
• 101000801224 Homo sapiens Acyl-coenzyme A thioesterase 11 Proteins 0.000 description 1
• 101000924577 Homo sapiens Adenomatous polyposis coli protein Proteins 0.000 description 1
• 101000924579 Homo sapiens Adenomatous polyposis coli protein 2 Proteins 0.000 description 1
• 101000783751 Homo sapiens Adenosine receptor A2a Proteins 0.000 description 1
• 101000959343 Homo sapiens Adenylate cyclase type 1 Proteins 0.000 description 1
• 101000775499 Homo sapiens Adenylate cyclase type 9 Proteins 0.000 description 1
• 101000796780 Homo sapiens Adhesion G protein-coupled receptor B1 Proteins 0.000 description 1
• 101000959594 Homo sapiens Agrin Proteins 0.000 description 1
• 101000717967 Homo sapiens Aldehyde dehydrogenase family 3 member A2 Proteins 0.000 description 1
• 101000717973 Homo sapiens Aldehyde dehydrogenase family 3 member B1 Proteins 0.000 description 1
• 101000928314 Homo sapiens Aldehyde oxidase Proteins 0.000 description 1
• 101000718041 Homo sapiens Aldo-keto reductase family 1 member B10 Proteins 0.000 description 1
• 101000690251 Homo sapiens Aldo-keto reductase family 1 member D1 Proteins 0.000 description 1
• 101000574440 Homo sapiens Alkaline phosphatase, germ cell type Proteins 0.000 description 1
• 101000756842 Homo sapiens Alpha-2A adrenergic receptor Proteins 0.000 description 1
• 101000929512 Homo sapiens Alpha-2B adrenergic receptor Proteins 0.000 description 1
• 101000799076 Homo sapiens Alpha-adducin Proteins 0.000 description 1
• 101000959152 Homo sapiens Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 Proteins 0.000 description 1
• 101000891530 Homo sapiens Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 Proteins 0.000 description 1
• 101000776186 Homo sapiens Amphoterin-induced protein 3 Proteins 0.000 description 1
• 101000890401 Homo sapiens Amyloid beta precursor like protein 2 Proteins 0.000 description 1
• 101000779309 Homo sapiens Amyloid protein-binding protein 2 Proteins 0.000 description 1
• 101000928690 Homo sapiens Amyloid-beta A4 precursor protein-binding family A member 1 Proteins 0.000 description 1
• 101000959823 Homo sapiens Amyloid-beta A4 precursor protein-binding family B member 3 Proteins 0.000 description 1
• 101000733825 Homo sapiens Anaphase-promoting complex subunit 11 Proteins 0.000 description 1
• 101000733832 Homo sapiens Anaphase-promoting complex subunit 13 Proteins 0.000 description 1
• 101000891154 Homo sapiens Angiomotin Proteins 0.000 description 1
• 101000891169 Homo sapiens Angiomotin-like protein 1 Proteins 0.000 description 1
• 101000964346 Homo sapiens Ankyrin repeat and BTB/POZ domain-containing protein 2 Proteins 0.000 description 1
• 101000694601 Homo sapiens Ankyrin repeat and SAM domain-containing protein 4B Proteins 0.000 description 1
• 101000780147 Homo sapiens Ankyrin repeat domain-containing protein 13B Proteins 0.000 description 1
• 101000889569 Homo sapiens Ankyrin repeat domain-containing protein 53 Proteins 0.000 description 1
• 101000796140 Homo sapiens Ankyrin-1 Proteins 0.000 description 1
• 101000928344 Homo sapiens Ankyrin-2 Proteins 0.000 description 1
• 101000928342 Homo sapiens Ankyrin-3 Proteins 0.000 description 1
• 101000771523 Homo sapiens Apelin Proteins 0.000 description 1
• 101000806793 Homo sapiens Apolipoprotein A-IV Proteins 0.000 description 1
• 101000793223 Homo sapiens Apolipoprotein C-III Proteins 0.000 description 1
• 101000971069 Homo sapiens Apoptosis facilitator Bcl-2-like protein 14 Proteins 0.000 description 1
• 101000757586 Homo sapiens Aprataxin Proteins 0.000 description 1
• 101000684459 Homo sapiens Aquaporin-11 Proteins 0.000 description 1
• 101000771417 Homo sapiens Aquaporin-8 Proteins 0.000 description 1
• 101000923072 Homo sapiens Armadillo repeat protein deleted in velo-cardio-facial syndrome Proteins 0.000 description 1
• 101000901111 Homo sapiens Arsenite methyltransferase Proteins 0.000 description 1
• 101000793115 Homo sapiens Aryl hydrocarbon receptor nuclear translocator Proteins 0.000 description 1
• 101000768838 Homo sapiens Aryl hydrocarbon receptor nuclear translocator 2 Proteins 0.000 description 1
• 101000925559 Homo sapiens Arylsulfatase D Proteins 0.000 description 1
• 101000884244 Homo sapiens Asparagine synthetase domain-containing protein 1 Proteins 0.000 description 1
• 101000901030 Homo sapiens Aspartyl/asparaginyl beta-hydroxylase Proteins 0.000 description 1
• 101000697938 Homo sapiens Attractin-like protein 1 Proteins 0.000 description 1
• 101000874569 Homo sapiens Axin-2 Proteins 0.000 description 1
• 101000798495 Homo sapiens B-cell CLL/lymphoma 9 protein Proteins 0.000 description 1
• 101000798491 Homo sapiens B-cell CLL/lymphoma 9-like protein Proteins 0.000 description 1
• 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 description 1
• 101000740057 Homo sapiens B-cell receptor-associated protein 29 Proteins 0.000 description 1
• 101000874270 Homo sapiens B-cell receptor-associated protein 31 Proteins 0.000 description 1
• 101000695703 Homo sapiens B2 bradykinin receptor Proteins 0.000 description 1
• 101000697871 Homo sapiens BAG family molecular chaperone regulator 3 Proteins 0.000 description 1
• 101000697866 Homo sapiens BAG family molecular chaperone regulator 4 Proteins 0.000 description 1
• 101000697498 Homo sapiens BAG family molecular chaperone regulator 5 Proteins 0.000 description 1
• 101000894690 Homo sapiens BCL-6 corepressor Proteins 0.000 description 1
• 101000894688 Homo sapiens BCL-6 corepressor-like protein 1 Proteins 0.000 description 1
• 101100165236 Homo sapiens BCOR gene Proteins 0.000 description 1
• 101000697376 Homo sapiens BET1-like protein Proteins 0.000 description 1
• 101000971073 Homo sapiens Bcl-2-like protein 12 Proteins 0.000 description 1
• 101000904691 Homo sapiens Bcl-2-like protein 2 Proteins 0.000 description 1
• 101000904597 Homo sapiens Beta-1,3-galactosyltransferase 5 Proteins 0.000 description 1
• 101000904594 Homo sapiens Beta-1,3-galactosyltransferase 6 Proteins 0.000 description 1
• 101000766145 Homo sapiens Beta-1,4-galactosyltransferase 1 Proteins 0.000 description 1
• 101000894883 Homo sapiens Beta-secretase 2 Proteins 0.000 description 1
• 101000697858 Homo sapiens Bile acid-CoA:amino acid N-acyltransferase Proteins 0.000 description 1
• 101000766212 Homo sapiens Brain-specific angiogenesis inhibitor 1-associated protein 2 Proteins 0.000 description 1
• 101000935635 Homo sapiens Breast carcinoma-amplified sequence 1 Proteins 0.000 description 1
• 101000766275 Homo sapiens Breast carcinoma-amplified sequence 4 Proteins 0.000 description 1
• 101000937839 Homo sapiens Bromo adjacent homology domain-containing 1 protein Proteins 0.000 description 1
• 101000971147 Homo sapiens Bromodomain adjacent to zinc finger domain protein 2A Proteins 0.000 description 1
• 101000964322 Homo sapiens C->U-editing enzyme APOBEC-2 Proteins 0.000 description 1
• 101000740689 Homo sapiens C4b-binding protein beta chain Proteins 0.000 description 1
• 101000934220 Homo sapiens CCN family member 5 Proteins 0.000 description 1
• 101000762247 Homo sapiens Cadherin-17 Proteins 0.000 description 1
• 101000867855 Homo sapiens Carbonic anhydrase 12 Proteins 0.000 description 1
• 101000698131 Homo sapiens Cell death regulator Aven Proteins 0.000 description 1
• 101000860881 Homo sapiens Coatomer subunit delta Proteins 0.000 description 1
• 101000710623 Homo sapiens Collagen alpha-1(XI) chain Proteins 0.000 description 1
• 101000936277 Homo sapiens Copper-transporting ATPase 1 Proteins 0.000 description 1
• 101000905751 Homo sapiens Cyclic AMP-dependent transcription factor ATF-6 alpha Proteins 0.000 description 1
• 101000884216 Homo sapiens Cyclin-G2 Proteins 0.000 description 1
• 101000753468 Homo sapiens Cysteine protease ATG4B Proteins 0.000 description 1
• 101000936854 Homo sapiens Cysteine protease ATG4D Proteins 0.000 description 1
• 101000922196 Homo sapiens Cysteine/serine-rich nuclear protein 1 Proteins 0.000 description 1
• 101000909111 Homo sapiens Cytochrome P450 4F11 Proteins 0.000 description 1
• 101000909121 Homo sapiens Cytochrome P450 4F3 Proteins 0.000 description 1
• 101000903587 Homo sapiens Cytosolic acyl coenzyme A thioester hydrolase Proteins 0.000 description 1
• 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 description 1
• 101000959356 Homo sapiens Disintegrin and metalloproteinase domain-containing protein 10 Proteins 0.000 description 1
• 101000777457 Homo sapiens Disintegrin and metalloproteinase domain-containing protein 12 Proteins 0.000 description 1
• 101000848629 Homo sapiens E3 ubiquitin-protein ligase TRIM22 Proteins 0.000 description 1
• 101000854471 Homo sapiens E3 ubiquitin-protein transferase RMND5A Proteins 0.000 description 1
• 101001065272 Homo sapiens EGF-containing fibulin-like extracellular matrix protein 1 Proteins 0.000 description 1
• 101000998777 Homo sapiens Early placenta insulin-like peptide Proteins 0.000 description 1
• 101000812663 Homo sapiens Endoplasmin Proteins 0.000 description 1
• 101001016782 Homo sapiens Ensconsin Proteins 0.000 description 1
• 101001010910 Homo sapiens Estrogen receptor beta Proteins 0.000 description 1
• 101000854648 Homo sapiens Ezrin Proteins 0.000 description 1
• 101000848171 Homo sapiens Fanconi anemia group J protein Proteins 0.000 description 1
• 101000917134 Homo sapiens Fibroblast growth factor receptor 4 Proteins 0.000 description 1
• 101000904261 Homo sapiens G patch domain and ankyrin repeat-containing protein 1 Proteins 0.000 description 1
• 101000697879 Homo sapiens Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 Proteins 0.000 description 1
• 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 description 1
• 101000857699 Homo sapiens Glycerol-3-phosphate acyltransferase 4 Proteins 0.000 description 1
• 101000585553 Homo sapiens Glycodelin Proteins 0.000 description 1
• 101001001336 Homo sapiens Guanylate-binding protein 1 Proteins 0.000 description 1
• 101000777624 Homo sapiens Hsp90 co-chaperone Cdc37-like 1 Proteins 0.000 description 1
• 101001054832 Homo sapiens Inhibin beta C chain Proteins 0.000 description 1
• 101001043764 Homo sapiens Inhibitor of nuclear factor kappa-B kinase subunit alpha Proteins 0.000 description 1
• 101000944277 Homo sapiens Inward rectifier potassium channel 2 Proteins 0.000 description 1
• 101000975502 Homo sapiens Keratin, type II cytoskeletal 7 Proteins 0.000 description 1
• 101001139134 Homo sapiens Krueppel-like factor 4 Proteins 0.000 description 1
• 101000718476 Homo sapiens L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase Proteins 0.000 description 1
• 101001034314 Homo sapiens Lactadherin Proteins 0.000 description 1
• 101000980823 Homo sapiens Leukocyte surface antigen CD53 Proteins 0.000 description 1
• 101000799318 Homo sapiens Long-chain-fatty-acid-CoA ligase 1 Proteins 0.000 description 1
• 101000780205 Homo sapiens Long-chain-fatty-acid-CoA ligase 5 Proteins 0.000 description 1
• 101000801625 Homo sapiens Long-chain-fatty-acid-CoA ligase ACSBG2 Proteins 0.000 description 1
• 101000984626 Homo sapiens Low-density lipoprotein receptor-related protein 12 Proteins 0.000 description 1
• 101001098256 Homo sapiens Lysophospholipase Proteins 0.000 description 1
• 101000940817 Homo sapiens Lysophospholipid acyltransferase LPCAT4 Proteins 0.000 description 1
• 101001001294 Homo sapiens Lysosomal acid phosphatase Proteins 0.000 description 1
• 101000576320 Homo sapiens Max-binding protein MNT Proteins 0.000 description 1
• 101000929655 Homo sapiens Monoacylglycerol lipase ABHD2 Proteins 0.000 description 1
• 101001133056 Homo sapiens Mucin-1 Proteins 0.000 description 1
• 101001128456 Homo sapiens Myosin regulatory light polypeptide 9 Proteins 0.000 description 1
• 101000873851 Homo sapiens N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 Proteins 0.000 description 1
• 101000886220 Homo sapiens N-acetylgalactosaminyltransferase 7 Proteins 0.000 description 1
• 101000874526 Homo sapiens N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 Proteins 0.000 description 1
• 101000874528 Homo sapiens N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3 Proteins 0.000 description 1
• 101000874530 Homo sapiens N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 4 Proteins 0.000 description 1
• 101000583053 Homo sapiens NGFI-A-binding protein 1 Proteins 0.000 description 1
• 101000624947 Homo sapiens Nesprin-1 Proteins 0.000 description 1
• 101000962058 Homo sapiens Neurobeachin-like protein 1 Proteins 0.000 description 1
• 101000603202 Homo sapiens Nicotinamide N-methyltransferase Proteins 0.000 description 1
• 101001137535 Homo sapiens Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 Proteins 0.000 description 1
• 101000836620 Homo sapiens Nucleic acid dioxygenase ALKBH1 Proteins 0.000 description 1
• 101000741956 Homo sapiens PRA1 family protein 3 Proteins 0.000 description 1
• 101000833892 Homo sapiens Peroxisomal acyl-coenzyme A oxidase 1 Proteins 0.000 description 1
• 101000833899 Homo sapiens Peroxisomal acyl-coenzyme A oxidase 2 Proteins 0.000 description 1
• 101001094028 Homo sapiens Phosphatase and actin regulator 2 Proteins 0.000 description 1
• 101000605434 Homo sapiens Phospholipid phosphatase 2 Proteins 0.000 description 1
• 101000801640 Homo sapiens Phospholipid-transporting ATPase ABCA3 Proteins 0.000 description 1
• 101000923328 Homo sapiens Phospholipid-transporting ATPase IG Proteins 0.000 description 1
• 101000923322 Homo sapiens Phospholipid-transporting ATPase IH Proteins 0.000 description 1
• 101000701520 Homo sapiens Phospholipid-transporting ATPase IK Proteins 0.000 description 1
• 101000728125 Homo sapiens Plasma membrane calcium-transporting ATPase 2 Proteins 0.000 description 1
• 101000728115 Homo sapiens Plasma membrane calcium-transporting ATPase 3 Proteins 0.000 description 1
• 101000595198 Homo sapiens Podocalyxin Proteins 0.000 description 1
• 101000829538 Homo sapiens Polypeptide N-acetylgalactosaminyltransferase 15 Proteins 0.000 description 1
• 101001064864 Homo sapiens Polyunsaturated fatty acid lipoxygenase ALOX12 Proteins 0.000 description 1
• 101001018494 Homo sapiens Pro-MCH Proteins 0.000 description 1
• 101000702559 Homo sapiens Probable global transcription activator SNF2L2 Proteins 0.000 description 1
• 101000799554 Homo sapiens Protein AATF Proteins 0.000 description 1
• 101000677836 Homo sapiens Protein ABHD13 Proteins 0.000 description 1
• 101000796953 Homo sapiens Protein ADM2 Proteins 0.000 description 1
• 101000800847 Homo sapiens Protein TFG Proteins 0.000 description 1
• 101000757196 Homo sapiens Protein angel homolog 1 Proteins 0.000 description 1
• 101000728107 Homo sapiens Putative Polycomb group protein ASXL2 Proteins 0.000 description 1
• 101000797918 Homo sapiens Putative aldo-keto reductase family 1 member C8 Proteins 0.000 description 1
• 101000780102 Homo sapiens Putative ankyrin repeat domain-containing protein 19 Proteins 0.000 description 1
• 101000996935 Homo sapiens Putative oxidoreductase GLYR1 Proteins 0.000 description 1
• 101000959153 Homo sapiens RNA demethylase ALKBH5 Proteins 0.000 description 1
• 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
• 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 1
• 101000856696 Homo sapiens Rho GDP-dissociation inhibitor 2 Proteins 0.000 description 1
• 101000856702 Homo sapiens Rho GDP-dissociation inhibitor 3 Proteins 0.000 description 1
• 101000581155 Homo sapiens Rho GTPase-activating protein 12 Proteins 0.000 description 1
• 101000581176 Homo sapiens Rho GTPase-activating protein 18 Proteins 0.000 description 1
• 101001091999 Homo sapiens Rho GTPase-activating protein 20 Proteins 0.000 description 1
• 101001091996 Homo sapiens Rho GTPase-activating protein 22 Proteins 0.000 description 1
• 101001091984 Homo sapiens Rho GTPase-activating protein 26 Proteins 0.000 description 1
• 101001075531 Homo sapiens Rho GTPase-activating protein 27 Proteins 0.000 description 1
• 101001075528 Homo sapiens Rho GTPase-activating protein 28 Proteins 0.000 description 1
• 101001106403 Homo sapiens Rho GTPase-activating protein 4 Proteins 0.000 description 1
• 101000752241 Homo sapiens Rho guanine nucleotide exchange factor 4 Proteins 0.000 description 1
• 101000752245 Homo sapiens Rho guanine nucleotide exchange factor 5 Proteins 0.000 description 1
• 101000927796 Homo sapiens Rho guanine nucleotide exchange factor 7 Proteins 0.000 description 1
• 101000927773 Homo sapiens Rho guanine nucleotide exchange factor 9 Proteins 0.000 description 1
• 101000945096 Homo sapiens Ribosomal protein S6 kinase alpha-5 Proteins 0.000 description 1
• 101000642656 Homo sapiens STE20-related kinase adapter protein beta Proteins 0.000 description 1
• 101000939246 Homo sapiens SUMO-conjugating enzyme UBC9 Proteins 0.000 description 1
• 101000936731 Homo sapiens Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 Proteins 0.000 description 1
• 101000936917 Homo sapiens Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 Proteins 0.000 description 1
• 101000632314 Homo sapiens Septin-6 Proteins 0.000 description 1
• 101000832685 Homo sapiens Small ubiquitin-related modifier 2 Proteins 0.000 description 1
• 101000829168 Homo sapiens Succinate-semialdehyde dehydrogenase, mitochondrial Proteins 0.000 description 1
• 101000763314 Homo sapiens Thrombomodulin Proteins 0.000 description 1
• 101000659879 Homo sapiens Thrombospondin-1 Proteins 0.000 description 1
• 101000891649 Homo sapiens Transcription elongation factor A protein-like 1 Proteins 0.000 description 1
• 101000701302 Homo sapiens Transcription factor ATOH8 Proteins 0.000 description 1
• 101000866298 Homo sapiens Transcription factor E2F8 Proteins 0.000 description 1
• 101000894871 Homo sapiens Transcription regulator protein BACH1 Proteins 0.000 description 1
• 101000904499 Homo sapiens Transcription regulator protein BACH2 Proteins 0.000 description 1
• 101000796673 Homo sapiens Transformation/transcription domain-associated protein Proteins 0.000 description 1
• 101000652736 Homo sapiens Transgelin Proteins 0.000 description 1
• 101000831866 Homo sapiens Transmembrane protein 45A Proteins 0.000 description 1
• 101000638251 Homo sapiens Tumor necrosis factor ligand superfamily member 9 Proteins 0.000 description 1
• 101000610609 Homo sapiens Tumor necrosis factor receptor superfamily member 10D Proteins 0.000 description 1
• 101000659324 Homo sapiens Twinfilin-1 Proteins 0.000 description 1
• 101000890951 Homo sapiens Type-2 angiotensin II receptor Proteins 0.000 description 1
• 101000971144 Homo sapiens Tyrosine-protein kinase BAZ1B Proteins 0.000 description 1
• 101001087418 Homo sapiens Tyrosine-protein phosphatase non-receptor type 12 Proteins 0.000 description 1
• 101000941126 Homo sapiens U3 small nucleolar RNA-associated protein 18 homolog Proteins 0.000 description 1
• 101000748161 Homo sapiens Ubiquitin carboxyl-terminal hydrolase 34 Proteins 0.000 description 1
• 101000761740 Homo sapiens Ubiquitin/ISG15-conjugating enzyme E2 L6 Proteins 0.000 description 1
• 101000850434 Homo sapiens V-type proton ATPase subunit B, brain isoform Proteins 0.000 description 1
• 101000850658 Homo sapiens Voltage-dependent anion-selective channel protein 3 Proteins 0.000 description 1
• 101000786318 Homo sapiens Zinc finger BED domain-containing protein 2 Proteins 0.000 description 1
• 101000833157 Homo sapiens Zinc finger protein AEBP2 Proteins 0.000 description 1
• 108091065455 Homo sapiens miR-130b stem-loop Proteins 0.000 description 1
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
• 102100031587 Hsp90 co-chaperone Cdc37-like 1 Human genes 0.000 description 1
• 108090000320 Hyaluronan Synthases Proteins 0.000 description 1
• 102000003918 Hyaluronan Synthases Human genes 0.000 description 1
• 102000004157 Hydrolases Human genes 0.000 description 1
• 108090000604 Hydrolases Proteins 0.000 description 1
• 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
• UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
• XDXDZDZNSLXDNA-TZNDIEGXSA-N Idarubicin Chemical compound C1[C@H](N)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2C[C@@](O)(C(C)=O)C1 XDXDZDZNSLXDNA-TZNDIEGXSA-N 0.000 description 1
• XDXDZDZNSLXDNA-UHFFFAOYSA-N Idarubicin Natural products C1C(N)C(O)C(C)OC1OC1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2CC(O)(C(C)=O)C1 XDXDZDZNSLXDNA-UHFFFAOYSA-N 0.000 description 1
• 208000026350 Inborn Genetic disease Diseases 0.000 description 1
• 101000607404 Infectious laryngotracheitis virus (strain Thorne V882) Protein UL24 homolog Proteins 0.000 description 1
• 102100026812 Inhibin beta C chain Human genes 0.000 description 1
• 102100021892 Inhibitor of nuclear factor kappa-B kinase subunit alpha Human genes 0.000 description 1
• 102000006992 Interferon-alpha Human genes 0.000 description 1
• 108010047761 Interferon-alpha Proteins 0.000 description 1
• 102000003996 Interferon-beta Human genes 0.000 description 1
• 108090000467 Interferon-beta Proteins 0.000 description 1
• 102000008070 Interferon-gamma Human genes 0.000 description 1
• 108010074328 Interferon-gamma Proteins 0.000 description 1
• 102000014150 Interferons Human genes 0.000 description 1
• 108010050904 Interferons Proteins 0.000 description 1
• 102000013462 Interleukin-12 Human genes 0.000 description 1
• 108010065805 Interleukin-12 Proteins 0.000 description 1
• 108090000978 Interleukin-4 Proteins 0.000 description 1
• 102000004388 Interleukin-4 Human genes 0.000 description 1
• 108090001005 Interleukin-6 Proteins 0.000 description 1
• 102000004889 Interleukin-6 Human genes 0.000 description 1
• 108090001007 Interleukin-8 Proteins 0.000 description 1
• 102100033114 Inward rectifier potassium channel 2 Human genes 0.000 description 1
• 102100023974 Keratin, type II cytoskeletal 7 Human genes 0.000 description 1
• 208000008839 Kidney Neoplasms Diseases 0.000 description 1
• 101000735632 Klebsiella pneumoniae Uncharacterized 8.8 kDa protein in aacA4 3'region Proteins 0.000 description 1
• 102100020677 Krueppel-like factor 4 Human genes 0.000 description 1
• 102100026384 L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase Human genes 0.000 description 1
• 102100039648 Lactadherin Human genes 0.000 description 1
• 108010000851 Laminin Receptors Proteins 0.000 description 1
• 102000002297 Laminin Receptors Human genes 0.000 description 1
• 102100020872 Leucyl-cystinyl aminopeptidase Human genes 0.000 description 1
• 102100024221 Leukocyte surface antigen CD53 Human genes 0.000 description 1
• 102000013519 Lipocalin-2 Human genes 0.000 description 1
• 108010051335 Lipocalin-2 Proteins 0.000 description 1
• GQYIWUVLTXOXAJ-UHFFFAOYSA-N Lomustine Chemical compound ClCCN(N=O)C(=O)NC1CCCCC1 GQYIWUVLTXOXAJ-UHFFFAOYSA-N 0.000 description 1
• 102100033995 Long-chain-fatty-acid-CoA ligase 1 Human genes 0.000 description 1
• 102100034318 Long-chain-fatty-acid-CoA ligase 5 Human genes 0.000 description 1
• 102100033564 Long-chain-fatty-acid-CoA ligase ACSBG1 Human genes 0.000 description 1
• 101710118200 Long-chain-fatty-acid-CoA ligase ACSBG2 Proteins 0.000 description 1
• 102100027120 Low-density lipoprotein receptor-related protein 12 Human genes 0.000 description 1
• 108060001084 Luciferase Proteins 0.000 description 1
• 239000005089 Luciferase Substances 0.000 description 1
• 206010025323 Lymphomas Diseases 0.000 description 1
• 102100037611 Lysophospholipase Human genes 0.000 description 1
• 102100031741 Lysophospholipid acyltransferase LPCAT4 Human genes 0.000 description 1
• 101710204480 Lysosomal acid phosphatase Proteins 0.000 description 1
• 102100020983 Lysosome membrane protein 2 Human genes 0.000 description 1
• 108091007772 MIRLET7C Proteins 0.000 description 1
• PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
• 108091027974 Mature messenger RNA Proteins 0.000 description 1
• 102100025169 Max-binding protein MNT Human genes 0.000 description 1
• 102100037258 Membrane-associated transporter protein Human genes 0.000 description 1
• 101710169257 Membrane-associated transporter protein Proteins 0.000 description 1
• 102000003735 Mesothelin Human genes 0.000 description 1
• 108090000015 Mesothelin Proteins 0.000 description 1
• 108060004795 Methyltransferase Proteins 0.000 description 1
• 102000016397 Methyltransferase Human genes 0.000 description 1
• 102100028134 Mitochondrial potassium channel ATP-binding subunit Human genes 0.000 description 1
• 101710106113 Mitochondrial potassium channel ATP-binding subunit Proteins 0.000 description 1
• 102100024193 Mitogen-activated protein kinase 1 Human genes 0.000 description 1
• PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 description 1
• 102100036617 Monoacylglycerol lipase ABHD2 Human genes 0.000 description 1
• 102100034256 Mucin-1 Human genes 0.000 description 1
• 206010073148 Multiple endocrine neoplasia type 2A Diseases 0.000 description 1
• 206010048723 Multiple-drug resistance Diseases 0.000 description 1
• 241001529936 Murinae Species 0.000 description 1
• 101001067395 Mus musculus Phospholipid scramblase 1 Proteins 0.000 description 1
• 101100425896 Mus musculus Tpm1 gene Proteins 0.000 description 1
• 241000699670 Mus sp. Species 0.000 description 1
• 241000186366 Mycobacterium bovis Species 0.000 description 1
• 102100031787 Myosin regulatory light polypeptide 9 Human genes 0.000 description 1
• 102100021003 N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase Human genes 0.000 description 1
• CBCQWVQNMGNYEO-UHFFFAOYSA-N N(6)-hydroxyadenine Chemical compound ONC1=NC=NC2=C1NC=N2 CBCQWVQNMGNYEO-UHFFFAOYSA-N 0.000 description 1
• 102100035854 N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 Human genes 0.000 description 1
• OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 description 1
• BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
• 102100039679 N-acetylgalactosaminyltransferase 7 Human genes 0.000 description 1
• 102100035628 N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 Human genes 0.000 description 1
• 102100035629 N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3 Human genes 0.000 description 1
• 102100035668 N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 4 Human genes 0.000 description 1
• 102100023648 N-chimaerin Human genes 0.000 description 1
• 101710140152 N-chimaerin Proteins 0.000 description 1
• 102100030407 NGFI-A-binding protein 1 Human genes 0.000 description 1
• 102100021867 Natural resistance-associated macrophage protein 2 Human genes 0.000 description 1
• 102100023306 Nesprin-1 Human genes 0.000 description 1
• 102100039231 Neurobeachin-like protein 1 Human genes 0.000 description 1
• 108010085793 Neurofibromin 1 Proteins 0.000 description 1
• 102000007530 Neurofibromin 1 Human genes 0.000 description 1
• 101100386699 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) dcl-1 gene Proteins 0.000 description 1
• 102100038951 Nicotinamide N-methyltransferase Human genes 0.000 description 1
• 102100021007 Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 Human genes 0.000 description 1
• 102100027051 Nucleic acid dioxygenase ALKBH1 Human genes 0.000 description 1
• AWZJFZMWSUBJAJ-UHFFFAOYSA-N OG-514 dye Chemical compound OC(=O)CSC1=C(F)C(F)=C(C(O)=O)C(C2=C3C=C(F)C(=O)C=C3OC3=CC(O)=C(F)C=C32)=C1F AWZJFZMWSUBJAJ-UHFFFAOYSA-N 0.000 description 1
• 102000043276 Oncogene Human genes 0.000 description 1
• 102100038660 PRA1 family protein 3 Human genes 0.000 description 1
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
• 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 1
• 102100026798 Peroxisomal acyl-coenzyme A oxidase 1 Human genes 0.000 description 1
• 102100026795 Peroxisomal acyl-coenzyme A oxidase 2 Human genes 0.000 description 1
• 108010081690 Pertussis Toxin Proteins 0.000 description 1
• 102100035266 Phosphatase and actin regulator 2 Human genes 0.000 description 1
• 102100033126 Phosphatidate cytidylyltransferase 2 Human genes 0.000 description 1
• 101710178746 Phosphatidate cytidylyltransferase 2 Proteins 0.000 description 1
• 101710114878 Phospholipase A-2-activating protein Proteins 0.000 description 1
• 102100038120 Phospholipid phosphatase 2 Human genes 0.000 description 1
• 102100033623 Phospholipid-transporting ATPase ABCA3 Human genes 0.000 description 1
• 102100032660 Phospholipid-transporting ATPase IG Human genes 0.000 description 1
• 102100032688 Phospholipid-transporting ATPase IH Human genes 0.000 description 1
• 108050001126 Phospholipid-transporting ATPase IK Proteins 0.000 description 1
• 101710171421 Phosphoprotein 32 Proteins 0.000 description 1
• 108091000080 Phosphotransferase Proteins 0.000 description 1
• 108010004729 Phycoerythrin Proteins 0.000 description 1
• 102100029744 Plasma membrane calcium-transporting ATPase 3 Human genes 0.000 description 1
• 102100022427 Plasmalemma vesicle-associated protein Human genes 0.000 description 1
• 101710193105 Plasmalemma vesicle-associated protein Proteins 0.000 description 1
• 241000223960 Plasmodium falciparum Species 0.000 description 1
• 102100036031 Podocalyxin Human genes 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 102100031949 Polyunsaturated fatty acid lipoxygenase ALOX12 Human genes 0.000 description 1
• 108010072970 Porphobilinogen synthase Proteins 0.000 description 1
• 102100033721 Pro-MCH Human genes 0.000 description 1
• 102100031021 Probable global transcription activator SNF2L2 Human genes 0.000 description 1
• 102100038277 Prostaglandin G/H synthase 1 Human genes 0.000 description 1
• 108050003243 Prostaglandin G/H synthase 1 Proteins 0.000 description 1
• 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 1
• 108010072866 Prostate-Specific Antigen Proteins 0.000 description 1
• 102100038358 Prostate-specific antigen Human genes 0.000 description 1
• 101710155502 Protein AATF Proteins 0.000 description 1
• 102100021500 Protein ABHD13 Human genes 0.000 description 1
• 102100033661 Protein TFG Human genes 0.000 description 1
• 102100022998 Protein angel homolog 1 Human genes 0.000 description 1
• 108010024221 Proto-Oncogene Proteins c-bcr Proteins 0.000 description 1
• 102100029750 Putative Polycomb group protein ASXL2 Human genes 0.000 description 1
• 102100032387 Putative aldo-keto reductase family 1 member C8 Human genes 0.000 description 1
• 102100034284 Putative ankyrin repeat domain-containing protein 19 Human genes 0.000 description 1
• 102100034301 Putative oxidoreductase GLYR1 Human genes 0.000 description 1
• 101150020518 RHEB gene Proteins 0.000 description 1
• 102100039083 RNA demethylase ALKBH5 Human genes 0.000 description 1
• 230000006819 RNA synthesis Effects 0.000 description 1
• 102100028208 Raftlin Human genes 0.000 description 1
• 101710159571 Raftlin Proteins 0.000 description 1
• 102100038914 RalA-binding protein 1 Human genes 0.000 description 1
• 102100034485 Ras-related protein Rab-2A Human genes 0.000 description 1
• 101710100968 Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
• 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 1
• 206010038389 Renal cancer Diseases 0.000 description 1
• 108050002653 Retinoblastoma protein Proteins 0.000 description 1
• 102100025622 Rho GDP-dissociation inhibitor 2 Human genes 0.000 description 1
• 102100027657 Rho GTPase-activating protein 10 Human genes 0.000 description 1
• 101710110392 Rho GTPase-activating protein 10 Proteins 0.000 description 1
• 101710110386 Rho GTPase-activating protein 12 Proteins 0.000 description 1
• 101710110410 Rho GTPase-activating protein 18 Proteins 0.000 description 1
• 102100027604 Rho GTPase-activating protein 19 Human genes 0.000 description 1
• 101710110404 Rho GTPase-activating protein 19 Proteins 0.000 description 1
• 101710116908 Rho GTPase-activating protein 2 Proteins 0.000 description 1
• 101710110420 Rho GTPase-activating protein 20 Proteins 0.000 description 1
• 101710110421 Rho GTPase-activating protein 21 Proteins 0.000 description 1
• 102100035757 Rho GTPase-activating protein 22 Human genes 0.000 description 1
• 102100035744 Rho GTPase-activating protein 26 Human genes 0.000 description 1
• 101710110413 Rho GTPase-activating protein 27 Proteins 0.000 description 1
• 101710110340 Rho GTPase-activating protein 28 Proteins 0.000 description 1
• 101710116901 Rho GTPase-activating protein 4 Proteins 0.000 description 1
• 102100021428 Rho GTPase-activating protein 5 Human genes 0.000 description 1
• 101710116909 Rho GTPase-activating protein 5 Proteins 0.000 description 1
• 101710128386 Rho guanine nucleotide exchange factor 4 Proteins 0.000 description 1
• 101710128382 Rho guanine nucleotide exchange factor 5 Proteins 0.000 description 1
• 102100033200 Rho guanine nucleotide exchange factor 7 Human genes 0.000 description 1
• 102100027609 Rho-related GTP-binding protein RhoD Human genes 0.000 description 1
• PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
• 102100033645 Ribosomal protein S6 kinase alpha-5 Human genes 0.000 description 1
• 108090000829 Ribosome Inactivating Proteins Proteins 0.000 description 1
• 108010039491 Ricin Proteins 0.000 description 1
• ZJUKTBDSGOFHSH-WFMPWKQPSA-N S-Adenosylhomocysteine Chemical compound O[C@@H]1[C@H](O)[C@@H](CSCC[C@H](N)C(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZJUKTBDSGOFHSH-WFMPWKQPSA-N 0.000 description 1
• 108010055623 S-Phase Kinase-Associated Proteins Proteins 0.000 description 1
• 102100034374 S-phase kinase-associated protein 2 Human genes 0.000 description 1
• 108091005488 SCARB2 Proteins 0.000 description 1
• 108091006618 SLC11A2 Proteins 0.000 description 1
• 108091006464 SLC25A23 Proteins 0.000 description 1
• 108091006264 SLC4A7 Proteins 0.000 description 1
• 102100035929 STE20-related kinase adapter protein beta Human genes 0.000 description 1
• 102100029807 SUMO-conjugating enzyme UBC9 Human genes 0.000 description 1
• 101100121445 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GCN20 gene Proteins 0.000 description 1
• 102100027697 Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 Human genes 0.000 description 1
• 102100027733 Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 Human genes 0.000 description 1
• 102100027982 Septin-6 Human genes 0.000 description 1
• 208000000453 Skin Neoplasms Diseases 0.000 description 1
• 102100024542 Small ubiquitin-related modifier 2 Human genes 0.000 description 1
• 102000006633 Sodium-Bicarbonate Symporters Human genes 0.000 description 1
• 101000818100 Spirochaeta aurantia Uncharacterized 12.7 kDa protein in trpE 5'region Proteins 0.000 description 1
• 102100025252 StAR-related lipid transfer protein 13 Human genes 0.000 description 1
• 238000012896 Statistical algorithm Methods 0.000 description 1
• 208000005718 Stomach Neoplasms Diseases 0.000 description 1
• 101001037658 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) Glucokinase Proteins 0.000 description 1
• 102100023673 Succinate-semialdehyde dehydrogenase, mitochondrial Human genes 0.000 description 1
• 108010000449 TNF-Related Apoptosis-Inducing Ligand Receptors Proteins 0.000 description 1
• 101710202131 Testicular acid phosphatase Proteins 0.000 description 1
• FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
• 102100036407 Thioredoxin Human genes 0.000 description 1
• 108091036066 Three prime untranslated region Proteins 0.000 description 1
• 102100026966 Thrombomodulin Human genes 0.000 description 1
• 102100036034 Thrombospondin-1 Human genes 0.000 description 1
• 102100030951 Tissue factor pathway inhibitor Human genes 0.000 description 1
• 102100030455 Transcription factor ATOH8 Human genes 0.000 description 1
• 102100031555 Transcription factor E2F8 Human genes 0.000 description 1
• 102100021268 Transcription regulator protein BACH1 Human genes 0.000 description 1
• 102100023998 Transcription regulator protein BACH2 Human genes 0.000 description 1
• 108010009583 Transforming Growth Factors Proteins 0.000 description 1
• 102000009618 Transforming Growth Factors Human genes 0.000 description 1
• 102100031013 Transgelin Human genes 0.000 description 1
• 102100024186 Transmembrane protein 45A Human genes 0.000 description 1
• 101001037292 Triticum aestivum Bowman-Birk type trypsin inhibitor Proteins 0.000 description 1
• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 1
• 102000018252 Tumor Protein p73 Human genes 0.000 description 1
• 108010091356 Tumor Protein p73 Proteins 0.000 description 1
• 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
• 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
• 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 1
• 108050002568 Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 1
• 102100032101 Tumor necrosis factor ligand superfamily member 9 Human genes 0.000 description 1
• 102100040110 Tumor necrosis factor receptor superfamily member 10D Human genes 0.000 description 1
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 1
• 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 description 1
• 102100036223 Twinfilin-1 Human genes 0.000 description 1
• 102100040372 Type-2 angiotensin II receptor Human genes 0.000 description 1
• 102000003425 Tyrosinase Human genes 0.000 description 1
• 108060008724 Tyrosinase Proteins 0.000 description 1
• 102100021575 Tyrosine-protein kinase BAZ1B Human genes 0.000 description 1
• 102100033020 Tyrosine-protein phosphatase non-receptor type 12 Human genes 0.000 description 1
• 102100031348 U3 small nucleolar RNA-associated protein 18 homolog Human genes 0.000 description 1
• 102100040048 Ubiquitin carboxyl-terminal hydrolase 35 Human genes 0.000 description 1
• 102100037587 Ubiquitin carboxyl-terminal hydrolase BAP1 Human genes 0.000 description 1
• 101710138903 Ubiquitin carboxyl-terminal hydrolase BAP1 Proteins 0.000 description 1
• 102100024843 Ubiquitin/ISG15-conjugating enzyme E2 L6 Human genes 0.000 description 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
• 102100033476 V-type proton ATPase subunit B, brain isoform Human genes 0.000 description 1
• JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 1
• 101710145727 Viral Fc-gamma receptor-like protein UL119 Proteins 0.000 description 1
• 102100033099 Voltage-dependent anion-selective channel protein 3 Human genes 0.000 description 1
• 108700020467 WT1 Proteins 0.000 description 1
• 101150084041 WT1 gene Proteins 0.000 description 1
• 102100025797 Zinc finger BED domain-containing protein 2 Human genes 0.000 description 1
• 101710126662 Zinc finger protein AEBP2 Proteins 0.000 description 1
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
• OTYCIBMYFBOSMG-XNIJJKJLSA-N [[(2r,3s,4r,5r)-5-[6-(6-aminohexylamino)purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C1=NC=2C(NCCCCCCN)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O OTYCIBMYFBOSMG-XNIJJKJLSA-N 0.000 description 1
• LVTQIVFSMGDIPF-IVZWLZJFSA-N [[(2r,3s,5r)-5-[4-amino-5-(3-aminoprop-1-ynyl)-2-oxopyrimidin-1-yl]-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O=C1N=C(N)C(C#CCN)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 LVTQIVFSMGDIPF-IVZWLZJFSA-N 0.000 description 1
• 101150010208 abcC13 gene Proteins 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 239000003070 absorption delaying agent Substances 0.000 description 1
• LLJZKKVYXXDWTB-UHFFFAOYSA-N acetic acid;sodium Chemical compound [Na].[Na].CC(O)=O LLJZKKVYXXDWTB-UHFFFAOYSA-N 0.000 description 1
• 108010012842 acetoacetyl-CoA synthetase Proteins 0.000 description 1
• 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
• 239000002253 acid Substances 0.000 description 1
• 230000002378 acidificating effect Effects 0.000 description 1
• 239000012190 activator Substances 0.000 description 1
• 239000008186 active pharmaceutical agent Substances 0.000 description 1
• 239000013543 active substance Substances 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 230000000996 additive effect Effects 0.000 description 1
• 229960000643 adenine Drugs 0.000 description 1
• 229960005305 adenosine Drugs 0.000 description 1
• UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
• LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 description 1
• 102000030621 adenylate cyclase Human genes 0.000 description 1
• 108060000200 adenylate cyclase Proteins 0.000 description 1
• 108010066700 adenylate cyclase 9 Proteins 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 229940009456 adriamycin Drugs 0.000 description 1
• 238000011256 aggressive treatment Methods 0.000 description 1
• 150000001298 alcohols Chemical class 0.000 description 1
• 150000001299 aldehydes Chemical class 0.000 description 1
• 229930013930 alkaloid Natural products 0.000 description 1
• 125000003282 alkyl amino group Chemical group 0.000 description 1
• 150000001350 alkyl halides Chemical class 0.000 description 1
• 150000008052 alkyl sulfonates Chemical class 0.000 description 1
• 150000001356 alkyl thiols Chemical group 0.000 description 1
• 230000029936 alkylation Effects 0.000 description 1
• 238000005804 alkylation reaction Methods 0.000 description 1
• 230000000172 allergic effect Effects 0.000 description 1
• 108010029483 alpha 1 Chain Collagen Type I Proteins 0.000 description 1
• 108020004101 alpha-2 Adrenergic Receptor Proteins 0.000 description 1
• HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
• 229950001537 amatuximab Drugs 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• 229940024606 amino acid Drugs 0.000 description 1
• 235000001014 amino acid Nutrition 0.000 description 1
• 150000001413 amino acids Chemical class 0.000 description 1
• 235000019257 ammonium acetate Nutrition 0.000 description 1
• 229940043376 ammonium acetate Drugs 0.000 description 1
• 238000012197 amplification kit Methods 0.000 description 1
• DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 description 1
• 201000008266 amyotrophic lateral sclerosis type 2 Diseases 0.000 description 1
• 230000033115 angiogenesis Effects 0.000 description 1
• 150000008064 anhydrides Chemical class 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 230000003302 anti-idiotype Effects 0.000 description 1
• 230000000845 anti-microbial effect Effects 0.000 description 1
• 230000002785 anti-thrombosis Effects 0.000 description 1
• 238000011319 anticancer therapy Methods 0.000 description 1
• 239000003146 anticoagulant agent Substances 0.000 description 1
• 229940045719 antineoplastic alkylating agent nitrosoureas Drugs 0.000 description 1
• 239000000074 antisense oligonucleotide Substances 0.000 description 1
• 238000012230 antisense oligonucleotides Methods 0.000 description 1
• BWVPHIKGXQBZPV-QKFDDRBGSA-N apelin Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N1[C@H](C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=2NC=NC=2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=2NC=NC=2)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CCSC)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(O)=O)CCC1 BWVPHIKGXQBZPV-QKFDDRBGSA-N 0.000 description 1
• 108010073614 apolipoprotein A-IV Proteins 0.000 description 1
• 238000003782 apoptosis assay Methods 0.000 description 1
• 108090001000 aquaporin 8 Proteins 0.000 description 1
• PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
• PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
• 150000001491 aromatic compounds Chemical class 0.000 description 1
• 229910052785 arsenic Inorganic materials 0.000 description 1
• RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
• 150000001502 aryl halides Chemical class 0.000 description 1
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
• 208000010668 atopic eczema Diseases 0.000 description 1
• 230000003305 autocrine Effects 0.000 description 1
• 150000001540 azides Chemical class 0.000 description 1
• 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
• 108700041737 bcl-2 Genes Proteins 0.000 description 1
• SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
• 239000003613 bile acid Substances 0.000 description 1
• 239000003124 biologic agent Substances 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 230000008236 biological pathway Effects 0.000 description 1
• 230000031018 biological processes and functions Effects 0.000 description 1
• 229960000074 biopharmaceutical Drugs 0.000 description 1
• 238000001815 biotherapy Methods 0.000 description 1
• 108010005713 bis(5'-adenosyl)triphosphatase Proteins 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• 210000001185 bone marrow Anatomy 0.000 description 1
• 229940077737 brain-derived neurotrophic factor Drugs 0.000 description 1
• 210000000069 breast epithelial cell Anatomy 0.000 description 1
• 125000001246 bromo group Chemical group Br* 0.000 description 1
• 102100039123 cAMP-regulated phosphoprotein 19 Human genes 0.000 description 1
• 102100039125 cAMP-regulated phosphoprotein 21 Human genes 0.000 description 1
• 238000004422 calculation algorithm Methods 0.000 description 1
• 108010051489 calin Proteins 0.000 description 1
• 230000009702 cancer cell proliferation Effects 0.000 description 1
• 238000005251 capillar electrophoresis Methods 0.000 description 1
• 238000001818 capillary gel electrophoresis Methods 0.000 description 1
• 125000002837 carbocyclic group Chemical group 0.000 description 1
• 125000004181 carboxyalkyl group Chemical group 0.000 description 1
• 229960005243 carmustine Drugs 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 150000001768 cations Chemical group 0.000 description 1
• 229960000590 celecoxib Drugs 0.000 description 1
• RZEKVGVHFLEQIL-UHFFFAOYSA-N celecoxib Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)F)=NN1C1=CC=C(S(N)(=O)=O)C=C1 RZEKVGVHFLEQIL-UHFFFAOYSA-N 0.000 description 1
• 210000004671 cell-free system Anatomy 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 210000003679 cervix uteri Anatomy 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• 230000003196 chaotropic effect Effects 0.000 description 1
• 239000002738 chelating agent Chemical group 0.000 description 1
• VYXSBFYARXAAKO-WTKGSRSZSA-N chembl402140 Chemical compound Cl.C1=2C=C(C)C(NCC)=CC=2OC2=C\C(=N/CC)C(C)=CC2=C1C1=CC=CC=C1C(=O)OCC VYXSBFYARXAAKO-WTKGSRSZSA-N 0.000 description 1
• 230000000973 chemotherapeutic effect Effects 0.000 description 1
• 125000001309 chloro group Chemical group Cl* 0.000 description 1
• 229960004926 chlorobutanol Drugs 0.000 description 1
• 230000002759 chromosomal effect Effects 0.000 description 1
• 238000003776 cleavage reaction Methods 0.000 description 1
• RAURUSFBVQLAPW-DNIKMYEQSA-N clocinnamox Chemical compound N1([C@@H]2CC3=CC=C(C=4O[C@@H]5[C@](C3=4)([C@]2(CCC5=O)NC(=O)\C=C\C=2C=CC(Cl)=CC=2)CC1)O)CC1CC1 RAURUSFBVQLAPW-DNIKMYEQSA-N 0.000 description 1
• 238000010367 cloning Methods 0.000 description 1
• 239000011248 coating agent Substances 0.000 description 1
• RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
• 239000005516 coenzyme A Substances 0.000 description 1
• 229940093530 coenzyme a Drugs 0.000 description 1
• 239000000084 colloidal system Substances 0.000 description 1
• 208000029742 colonic neoplasm Diseases 0.000 description 1
• 230000005757 colony formation Effects 0.000 description 1
• 238000009096 combination chemotherapy Methods 0.000 description 1
• 239000002299 complementary DNA Substances 0.000 description 1
• 230000036461 convulsion Effects 0.000 description 1
• 229960000956 coumarin Drugs 0.000 description 1
• 235000001671 coumarin Nutrition 0.000 description 1
• GLNDAGDHSLMOKX-UHFFFAOYSA-N coumarin 120 Chemical compound C1=C(N)C=CC2=C1OC(=O)C=C2C GLNDAGDHSLMOKX-UHFFFAOYSA-N 0.000 description 1
• 230000008878 coupling Effects 0.000 description 1
• 238000010168 coupling process Methods 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 229940111134 coxibs Drugs 0.000 description 1
• 238000002681 cryosurgery Methods 0.000 description 1
• 210000004748 cultured cell Anatomy 0.000 description 1
• 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 1
• 108010049998 cyclic AMP-regulated phosphoprotein 19 Proteins 0.000 description 1
• 108010083633 cyclic AMP-regulated phosphoprotein ARPP-21 Proteins 0.000 description 1
• 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 description 1
• 230000002559 cytogenic effect Effects 0.000 description 1
• 210000004292 cytoskeleton Anatomy 0.000 description 1
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
• RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
• HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
• GYOZYWVXFNDGLU-XLPZGREQSA-N dTMP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)C1 GYOZYWVXFNDGLU-XLPZGREQSA-N 0.000 description 1
• NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
• JSRLJPSBLDHEIO-SHYZEUOFSA-N dUMP Chemical compound O1[C@H](COP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 JSRLJPSBLDHEIO-SHYZEUOFSA-N 0.000 description 1
• 229960003901 dacarbazine Drugs 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 230000001419 dependent effect Effects 0.000 description 1
• KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
• 150000004891 diazines Chemical class 0.000 description 1
• QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
• SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
• UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 1
• 239000001177 diphosphate Substances 0.000 description 1
• 235000011180 diphosphates Nutrition 0.000 description 1
• 230000005750 disease progression Effects 0.000 description 1
• 208000035475 disorder Diseases 0.000 description 1
• 229960004679 doxorubicin Drugs 0.000 description 1
• 230000036267 drug metabolism Effects 0.000 description 1
• 229920001971 elastomer Polymers 0.000 description 1
• 230000003028 elevating effect Effects 0.000 description 1
• 229960004137 elotuzumab Drugs 0.000 description 1
• 238000010828 elution Methods 0.000 description 1
• 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
• 239000003623 enhancer Substances 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• 229950009760 epratuzumab Drugs 0.000 description 1
• 230000008029 eradication Effects 0.000 description 1
• 210000003743 erythrocyte Anatomy 0.000 description 1
• 201000004101 esophageal cancer Diseases 0.000 description 1
• 229940011871 estrogen Drugs 0.000 description 1
• 239000000262 estrogen Substances 0.000 description 1
• BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
• 210000003527 eukaryotic cell Anatomy 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 239000013604 expression vector Substances 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 230000001605 fetal effect Effects 0.000 description 1
• 210000002950 fibroblast Anatomy 0.000 description 1
• 108700014844 flt3 ligand Proteins 0.000 description 1
• 229960000390 fludarabine Drugs 0.000 description 1
• GIUYCYHIANZCFB-FJFJXFQQSA-N fludarabine phosphate Chemical compound C1=NC=2C(N)=NC(F)=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O GIUYCYHIANZCFB-FJFJXFQQSA-N 0.000 description 1
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
• 239000007850 fluorescent dye Substances 0.000 description 1
• 125000001153 fluoro group Chemical group F* 0.000 description 1
• 238000005558 fluorometry Methods 0.000 description 1
• 210000003953 foreskin Anatomy 0.000 description 1
• 239000012458 free base Substances 0.000 description 1
• 125000000524 functional group Chemical group 0.000 description 1
• 108010028963 galactosylgalactoylxylosylprotein 3-beta-glucuronosyltransferase Proteins 0.000 description 1
• 210000001035 gastrointestinal tract Anatomy 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 229960003297 gemtuzumab ozogamicin Drugs 0.000 description 1
• 238000001476 gene delivery Methods 0.000 description 1
• 208000016361 genetic disease Diseases 0.000 description 1
• 108010076790 germ-cell AP isoenzyme Proteins 0.000 description 1
• 230000000762 glandular Effects 0.000 description 1
• 239000003365 glass fiber Substances 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 108010014977 glycine cleavage system Proteins 0.000 description 1
• 229940015043 glyoxal Drugs 0.000 description 1
• 239000005090 green fluorescent protein Substances 0.000 description 1
• 230000012010 growth Effects 0.000 description 1
• 239000003102 growth factor Substances 0.000 description 1
• 230000009036 growth inhibition Effects 0.000 description 1
• ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
• 210000003780 hair follicle Anatomy 0.000 description 1
• 150000004820 halides Chemical class 0.000 description 1
• 229910052736 halogen Inorganic materials 0.000 description 1
• 150000002367 halogens Chemical class 0.000 description 1
• 101150055960 hemB gene Proteins 0.000 description 1
• 229940022353 herceptin Drugs 0.000 description 1
• 125000005842 heteroatom Chemical group 0.000 description 1
• 125000000623 heterocyclic group Chemical group 0.000 description 1
• 239000000833 heterodimer Substances 0.000 description 1
• 238000004128 high performance liquid chromatography Methods 0.000 description 1
• 230000001744 histochemical effect Effects 0.000 description 1
• 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
• 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
• 230000006951 hyperphosphorylation Effects 0.000 description 1
• 229960001001 ibritumomab tiuxetan Drugs 0.000 description 1
• 229960000908 idarubicin Drugs 0.000 description 1
• 150000002463 imidates Chemical class 0.000 description 1
• LFKYBJLFJOOKAE-UHFFFAOYSA-N imidazol-2-ylidenemethanone Chemical compound O=C=C1N=CC=N1 LFKYBJLFJOOKAE-UHFFFAOYSA-N 0.000 description 1
• 238000003119 immunoblot Methods 0.000 description 1
• 238000010166 immunofluorescence Methods 0.000 description 1
• 239000002955 immunomodulating agent Substances 0.000 description 1
• 230000001024 immunotherapeutic effect Effects 0.000 description 1
• 238000007901 in situ hybridization Methods 0.000 description 1
• 238000011065 in-situ storage Methods 0.000 description 1
• 230000002779 inactivation Effects 0.000 description 1
• 230000006882 induction of apoptosis Effects 0.000 description 1
• 208000000509 infertility Diseases 0.000 description 1
• 230000036512 infertility Effects 0.000 description 1
• 208000021267 infertility disease Diseases 0.000 description 1
• 108091008042 inhibitory receptors Proteins 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 229910052500 inorganic mineral Inorganic materials 0.000 description 1
• 102000006495 integrins Human genes 0.000 description 1
• 108010044426 integrins Proteins 0.000 description 1
• 230000035990 intercellular signaling Effects 0.000 description 1
• 229940047124 interferons Drugs 0.000 description 1
• 108040006849 interleukin-2 receptor activity proteins Proteins 0.000 description 1
• 108090000237 interleukin-24 Proteins 0.000 description 1
• 102000003898 interleukin-24 Human genes 0.000 description 1
• 239000000543 intermediate Substances 0.000 description 1
• 230000000968 intestinal effect Effects 0.000 description 1
• 238000007917 intracranial administration Methods 0.000 description 1
• 238000011835 investigation Methods 0.000 description 1
• 125000002346 iodo group Chemical group I* 0.000 description 1
• 229960005386 ipilimumab Drugs 0.000 description 1
• 239000012948 isocyanate Substances 0.000 description 1
• 150000002513 isocyanates Chemical class 0.000 description 1
• 150000002540 isothiocyanates Chemical class 0.000 description 1
• 208000032799 juvenile amyotrophic lateral sclerosis type 2 Diseases 0.000 description 1
• 201000010982 kidney cancer Diseases 0.000 description 1
• 230000002147 killing effect Effects 0.000 description 1
• 229910021644 lanthanide ion Inorganic materials 0.000 description 1
• 230000001418 larval effect Effects 0.000 description 1
• 210000000867 larynx Anatomy 0.000 description 1
• 238000002430 laser surgery Methods 0.000 description 1
• 229940067606 lecithin Drugs 0.000 description 1
• 235000010445 lecithin Nutrition 0.000 description 1
• 239000000787 lecithin Substances 0.000 description 1
• 108091091807 let-7a stem-loop Proteins 0.000 description 1
• 108091057746 let-7a-4 stem-loop Proteins 0.000 description 1
• 108091028376 let-7a-5 stem-loop Proteins 0.000 description 1
• 108091024393 let-7a-6 stem-loop Proteins 0.000 description 1
• 108091091174 let-7a-7 stem-loop Proteins 0.000 description 1
• 108091007423 let-7b Proteins 0.000 description 1
• 229950002884 lexatumumab Drugs 0.000 description 1
• 108091053735 lin-4 stem-loop Proteins 0.000 description 1
• 108091032363 lin-4-1 stem-loop Proteins 0.000 description 1
• 108091028008 lin-4-2 stem-loop Proteins 0.000 description 1
• 229950002950 lintuzumab Drugs 0.000 description 1
• 230000037356 lipid metabolism Effects 0.000 description 1
• 108010081442 lipidosin Proteins 0.000 description 1
• 108010013555 lipoprotein-associated coagulation inhibitor Proteins 0.000 description 1
• 239000002502 liposome Substances 0.000 description 1
• 238000011068 loading method Methods 0.000 description 1
• 229960002247 lomustine Drugs 0.000 description 1
• DHMTURDWPRKSOA-RUZDIDTESA-N lonafarnib Chemical compound C1CN(C(=O)N)CCC1CC(=O)N1CCC([C@@H]2C3=C(Br)C=C(Cl)C=C3CCC3=CC(Br)=CN=C32)CC1 DHMTURDWPRKSOA-RUZDIDTESA-N 0.000 description 1
• 229950001750 lonafarnib Drugs 0.000 description 1
• PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 description 1
• 229960004844 lovastatin Drugs 0.000 description 1
• QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 description 1
• 229950004563 lucatumumab Drugs 0.000 description 1
• 208000037841 lung tumor Diseases 0.000 description 1
• 210000004324 lymphatic system Anatomy 0.000 description 1
• 210000004698 lymphocyte Anatomy 0.000 description 1
• 230000002132 lysosomal effect Effects 0.000 description 1
• 230000036210 malignancy Effects 0.000 description 1
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
• 210000004962 mammalian cell Anatomy 0.000 description 1
• 229950008001 matuzumab Drugs 0.000 description 1
• 230000010534 mechanism of action Effects 0.000 description 1
• 230000001404 mediated effect Effects 0.000 description 1
• 210000004379 membrane Anatomy 0.000 description 1
• 239000012528 membrane Substances 0.000 description 1
• 230000023881 membrane protein ectodomain proteolysis Effects 0.000 description 1
• GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 description 1
• 230000001394 metastastic effect Effects 0.000 description 1
• 208000037819 metastatic cancer Diseases 0.000 description 1
• 208000011575 metastatic malignant neoplasm Diseases 0.000 description 1
• 238000007069 methylation reaction Methods 0.000 description 1
• 108091008057 miR-10 Proteins 0.000 description 1
• 108091026805 miR-10 stem-loop Proteins 0.000 description 1
• 108091028466 miR-130b stem-loop Proteins 0.000 description 1
• 108091049773 miR-14 stem-loop Proteins 0.000 description 1
• 108091056204 miR-16-2 stem-loop Proteins 0.000 description 1
• 108091061970 miR-26a stem-loop Proteins 0.000 description 1
• 108091088670 miR-33-1 stem-loop Proteins 0.000 description 1
• 108091074487 miR-34 stem-loop Proteins 0.000 description 1
• 108091092493 miR-34-1 stem-loop Proteins 0.000 description 1
• 108091059780 miR-34-2 stem-loop Proteins 0.000 description 1
• 108091029119 miR-34a stem-loop Proteins 0.000 description 1
• 108091023818 miR-7 stem-loop Proteins 0.000 description 1
• 108091037014 miR-7-1 stem-loop Proteins 0.000 description 1
• 108091030520 miR-7-2 stem-loop Proteins 0.000 description 1
• 108091025113 miR-7-3 stem-loop Proteins 0.000 description 1
• 239000011707 mineral Substances 0.000 description 1
• 235000010755 mineral Nutrition 0.000 description 1
• 239000002991 molded plastic Substances 0.000 description 1
• 238000000329 molecular dynamics simulation Methods 0.000 description 1
• 239000003068 molecular probe Substances 0.000 description 1
• 108010066416 multidrug resistance-associated protein 3 Proteins 0.000 description 1
• 206010051747 multiple endocrine neoplasia Diseases 0.000 description 1
• 229940087004 mustargen Drugs 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• 210000004165 myocardium Anatomy 0.000 description 1
• NJHLGKJQFKUSEA-UHFFFAOYSA-N n-[2-(4-hydroxyphenyl)ethyl]-n-methylnitrous amide Chemical compound O=NN(C)CCC1=CC=C(O)C=C1 NJHLGKJQFKUSEA-UHFFFAOYSA-N 0.000 description 1
• 210000000822 natural killer cell Anatomy 0.000 description 1
• 230000014399 negative regulation of angiogenesis Effects 0.000 description 1
• 230000006654 negative regulation of apoptotic process Effects 0.000 description 1
• 125000003835 nucleoside group Chemical group 0.000 description 1
• 229960002450 ofatumumab Drugs 0.000 description 1
• 239000003921 oil Substances 0.000 description 1
• 235000019198 oils Nutrition 0.000 description 1
• 239000003960 organic solvent Substances 0.000 description 1
• AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 238000007254 oxidation reaction Methods 0.000 description 1
• 229910052760 oxygen Inorganic materials 0.000 description 1
• 239000001301 oxygen Substances 0.000 description 1
• 125000004430 oxygen atom Chemical group O* 0.000 description 1
• VYNDHICBIRRPFP-UHFFFAOYSA-N pacific blue Chemical compound FC1=C(O)C(F)=C2OC(=O)C(C(=O)O)=CC2=C1 VYNDHICBIRRPFP-UHFFFAOYSA-N 0.000 description 1
• 238000011499 palliative surgery Methods 0.000 description 1
• 201000002528 pancreatic cancer Diseases 0.000 description 1
• 229960001972 panitumumab Drugs 0.000 description 1
• 230000003076 paracrine Effects 0.000 description 1
• 244000045947 parasite Species 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 230000000737 periodic effect Effects 0.000 description 1
• 229960002087 pertuzumab Drugs 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• 229960003742 phenol Drugs 0.000 description 1
• NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 1
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
• 150000008300 phosphoramidites Chemical class 0.000 description 1
• OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 102000020233 phosphotransferase Human genes 0.000 description 1
• 230000035479 physiological effects, processes and functions Effects 0.000 description 1
• BLFWHYXWBKKRHI-JYBILGDPSA-N plap Chemical compound N([C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](N)CCC(O)=O BLFWHYXWBKKRHI-JYBILGDPSA-N 0.000 description 1
• 229920002401 polyacrylamide Polymers 0.000 description 1
• 229920000642 polymer Polymers 0.000 description 1
• 238000003752 polymerase chain reaction Methods 0.000 description 1
• 229920005862 polyol Polymers 0.000 description 1
• 150000003077 polyols Chemical class 0.000 description 1
• 230000017363 positive regulation of growth Effects 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• 238000001556 precipitation Methods 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 230000002335 preservative effect Effects 0.000 description 1
• 230000000861 pro-apoptotic effect Effects 0.000 description 1
• 230000005522 programmed cell death Effects 0.000 description 1
• 230000002062 proliferating effect Effects 0.000 description 1
• 230000002035 prolonged effect Effects 0.000 description 1
• 230000001737 promoting effect Effects 0.000 description 1
• VYXXMAGSIYIYGD-NWAYQTQBSA-N propan-2-yl 2-[[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(pyrimidine-4-carbonylamino)phosphoryl]amino]-2-methylpropanoate Chemical compound CC(C)OC(=O)C(C)(C)NP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc12)NC(=O)c1ccncn1 VYXXMAGSIYIYGD-NWAYQTQBSA-N 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• 208000023958 prostate neoplasm Diseases 0.000 description 1
• 238000002731 protein assay Methods 0.000 description 1
• 239000003528 protein farnesyltransferase inhibitor Substances 0.000 description 1
• 238000001243 protein synthesis Methods 0.000 description 1
• 238000010926 purge Methods 0.000 description 1
• IGFXRKMLLMBKSA-UHFFFAOYSA-N purine Chemical compound N1=C[N]C2=NC=NC2=C1 IGFXRKMLLMBKSA-UHFFFAOYSA-N 0.000 description 1
• JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
• 150000003222 pyridines Chemical class 0.000 description 1
• 125000000714 pyrimidinyl group Chemical group 0.000 description 1
• 239000002510 pyrogen Substances 0.000 description 1
• 108010067765 rab2 GTP Binding protein Proteins 0.000 description 1
• 238000011363 radioimmunotherapy Methods 0.000 description 1
• 102000016914 ras Proteins Human genes 0.000 description 1
• 108010014186 ras Proteins Proteins 0.000 description 1
• 239000011541 reaction mixture Substances 0.000 description 1
• 238000010188 recombinant method Methods 0.000 description 1
• 238000011084 recovery Methods 0.000 description 1
• 235000003499 redwood Nutrition 0.000 description 1
• 230000010076 replication Effects 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 108010004650 rho GTPase-activating protein Proteins 0.000 description 1
• 108010084871 rho Guanine Nucleotide Dissociation Inhibitor alpha Proteins 0.000 description 1
• 108010013035 rho Guanine Nucleotide Dissociation Inhibitor gamma Proteins 0.000 description 1
• XFKVYXCRNATCOO-UHFFFAOYSA-M rhodamine 6G Chemical compound [Cl-].C=12C=C(C)C(NCC)=CC2=[O+]C=2C=C(NCC)C(C)=CC=2C=1C1=CC=CC=C1C(=O)OCC XFKVYXCRNATCOO-UHFFFAOYSA-M 0.000 description 1
• 239000001022 rhodamine dye Substances 0.000 description 1
• 239000003161 ribonuclease inhibitor Substances 0.000 description 1
• 238000005096 rolling process Methods 0.000 description 1
• 210000003296 saliva Anatomy 0.000 description 1
• 210000001908 sarcoplasmic reticulum Anatomy 0.000 description 1
• 108700004121 sarkosyl Proteins 0.000 description 1
• 230000007017 scission Effects 0.000 description 1
• 238000012216 screening Methods 0.000 description 1
• 210000000582 semen Anatomy 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 230000035939 shock Effects 0.000 description 1
• 230000011664 signaling Effects 0.000 description 1
• 230000007781 signaling event Effects 0.000 description 1
• 239000010703 silicon Substances 0.000 description 1
• 229910052710 silicon Inorganic materials 0.000 description 1
• 229960003323 siltuximab Drugs 0.000 description 1
• 229950003804 siplizumab Drugs 0.000 description 1
• 201000000849 skin cancer Diseases 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 210000002460 smooth muscle Anatomy 0.000 description 1
• 239000001632 sodium acetate Substances 0.000 description 1
• 235000017281 sodium acetate Nutrition 0.000 description 1
• 239000007790 solid phase Substances 0.000 description 1
• 239000004334 sorbic acid Substances 0.000 description 1
• 235000010199 sorbic acid Nutrition 0.000 description 1
• 229940075582 sorbic acid Drugs 0.000 description 1
• 230000003393 splenic effect Effects 0.000 description 1
• 238000002719 stereotactic radiosurgery Methods 0.000 description 1
• 201000011549 stomach cancer Diseases 0.000 description 1
• 210000002948 striated muscle cell Anatomy 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 150000003461 sulfonyl halides Chemical class 0.000 description 1
• 125000004962 sulfoxyl group Chemical group 0.000 description 1
• 239000000725 suspension Substances 0.000 description 1
• 238000013268 sustained release Methods 0.000 description 1
• 239000012730 sustained-release form Substances 0.000 description 1
• 230000002195 synergetic effect Effects 0.000 description 1
• 238000001308 synthesis method Methods 0.000 description 1
• 230000002194 synthesizing effect Effects 0.000 description 1
• 101150047061 tag-72 gene Proteins 0.000 description 1
• 210000001138 tear Anatomy 0.000 description 1
• WWJZWCUNLNYYAU-UHFFFAOYSA-N temephos Chemical compound C1=CC(OP(=S)(OC)OC)=CC=C1SC1=CC=C(OP(=S)(OC)OC)C=C1 WWJZWCUNLNYYAU-UHFFFAOYSA-N 0.000 description 1
• 229960003604 testosterone Drugs 0.000 description 1
• MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
• IBVCSSOEYUMRLC-GABYNLOESA-N texas red-5-dutp Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C(C#CCNS(=O)(=O)C=2C=C(C(C=3C4=CC=5CCCN6CCCC(C=56)=C4OC4=C5C6=[N+](CCC5)CCCC6=CC4=3)=CC=2)S([O-])(=O)=O)=C1 IBVCSSOEYUMRLC-GABYNLOESA-N 0.000 description 1
• RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
• 229940033663 thimerosal Drugs 0.000 description 1
• ZEMGGZBWXRYJHK-UHFFFAOYSA-N thiouracil Chemical compound O=C1C=CNC(=S)N1 ZEMGGZBWXRYJHK-UHFFFAOYSA-N 0.000 description 1
• 229950000329 thiouracil Drugs 0.000 description 1
• 229940104230 thymidine Drugs 0.000 description 1
• 229940113082 thymine Drugs 0.000 description 1
• 229960003087 tioguanine Drugs 0.000 description 1
• PLHJCIYEEKOWNM-HHHXNRCGSA-N tipifarnib Chemical compound CN1C=NC=C1[C@](N)(C=1C=C2C(C=3C=C(Cl)C=CC=3)=CC(=O)N(C)C2=CC=1)C1=CC=C(Cl)C=C1 PLHJCIYEEKOWNM-HHHXNRCGSA-N 0.000 description 1
• 229950009158 tipifarnib Drugs 0.000 description 1
• 210000002105 tongue Anatomy 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 238000013518 transcription Methods 0.000 description 1
• 230000035897 transcription Effects 0.000 description 1
• 238000012546 transfer Methods 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 230000007704 transition Effects 0.000 description 1
• 230000001960 triggered effect Effects 0.000 description 1
• 230000004614 tumor growth Effects 0.000 description 1
• 102000003298 tumor necrosis factor receptor Human genes 0.000 description 1
• 239000000225 tumor suppressor protein Substances 0.000 description 1
• 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
• 238000002211 ultraviolet spectrum Methods 0.000 description 1
• 230000004222 uncontrolled growth Effects 0.000 description 1
• 238000011144 upstream manufacturing Methods 0.000 description 1
• 229940035893 uracil Drugs 0.000 description 1
• 229950005972 urelumab Drugs 0.000 description 1
• 230000002485 urinary effect Effects 0.000 description 1
• 210000004291 uterus Anatomy 0.000 description 1
• 210000005166 vasculature Anatomy 0.000 description 1
• 235000015112 vegetable and seed oil Nutrition 0.000 description 1
• 239000008158 vegetable oil Substances 0.000 description 1
• JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 description 1
• 210000000605 viral structure Anatomy 0.000 description 1
• 238000001429 visible spectrum Methods 0.000 description 1
• 238000007794 visualization technique Methods 0.000 description 1
• 229950001212 volociximab Drugs 0.000 description 1
• 239000011534 wash buffer Substances 0.000 description 1
• 229940075420 xanthine Drugs 0.000 description 1